GRK5
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00115 | S57 | Sugiyama | DNASE2 DNASE2A DNL2 | ALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGR |
| O00170 | S43 | Sugiyama | AIP XAP2 | GELPDFQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELI |
| O00592 | T556 | Sugiyama | PODXL PCLP PCLP1 | DsWIVPLDNLTKDDLDEEEDtHL__________________ |
| O43615 | S94 | Sugiyama | TIMM44 MIMT44 TIM44 | NKEMKESIKKFRDEARRLEEsDVLQEARRKyKtIESETVRT |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60264 | S825 | Sugiyama | SMARCA5 SNF2H WCRF135 | ELPNAAQAQKEEQLKIDEAEsLNDEELEEKEKLLTQGFTNW |
| O60353 | S648 | PSP | FZD6 | LsGEQVDGKGQAGsVSESARsEGRIsPKsDItDtGLAQSNN |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60832 | S453 | Sugiyama | DKC1 NOLA4 | KAPQVVAEAAKTAKRKREsEsEsDEtPPAAPQLIKKEKKKS |
| O60841 | S113 | Sugiyama | EIF5B IF2 KIAA0741 | sKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTAKPKVEM |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75581 | S1490 | GPS6|EPSD | LRP6 | SSSSssTKGtYFPAILNPPPsPAtERsHYTMEFGYSsNsPs |
| O76070 | S124 | iPTMNet|EPSD | SNCG BCSG1 PERSYN PRSN | APQQEGEAsKEKEEVAEEAQsGGD_________________ |
| O95155 | S118 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | QsLsRsQsMDIDGVSCEKsMsQVDVDsGIENMEVDENDRRE |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95757 | S508 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | GIFSVASASVIEKQNLEGDHsDAPMETEtsFKNENKDNMDK |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04080 | T96 | Sugiyama | CSTB CST6 STFB | ENKPLtLsNyQTNKAKHDELtyF__________________ |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04637 | T55 | GPS6|SIGNOR|EPSD|PSP | TP53 P53 | LPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRMPEAAPPVAP |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P05187 | S434 | Sugiyama | ALPP PLAP | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETH |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05198 | T281 | Sugiyama | EIF2S1 EIF2A | KIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVD |
| P05198 | T284 | Sugiyama | EIF2S1 EIF2A | EKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVDGDD |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05556 | S509 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | CRCNEGRVGRHCECstDEVNsEDMDAYCRKENSSEICSNNG |
| P05787 | S475 | Sugiyama | KRT8 CYK8 | TSSSRAVVVKKIETRDGKLVsEssDVLPK____________ |
| P05787 | S477 | Sugiyama | KRT8 CYK8 | SSRAVVVKKIETRDGKLVsEssDVLPK______________ |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07550 | S355 | EPSD|PSP | ADRB2 ADRB2R B2AR | AFQELLCLRRssLKAyGNGyssNGNtGEQsGYHVEQEKENK |
| P07550 | S356 | EPSD|PSP | ADRB2 ADRB2R B2AR | FQELLCLRRssLKAyGNGyssNGNtGEQsGYHVEQEKENKL |
| P07550 | S396 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADRB2 ADRB2R B2AR | LLCEDLPGtEDFVGHQGtVPsDNIDsQGRNCstNDsLL___ |
| P07550 | S401 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADRB2 ADRB2R B2AR | LPGtEDFVGHQGtVPsDNIDsQGRNCstNDsLL________ |
| P07550 | S407 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADRB2 ADRB2R B2AR | FVGHQGtVPsDNIDsQGRNCstNDsLL______________ |
| P07550 | S411 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADRB2 ADRB2R B2AR | QGtVPsDNIDsQGRNCstNDsLL__________________ |
| P07550 | T384 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADRB2 ADRB2R B2AR | sGYHVEQEKENKLLCEDLPGtEDFVGHQGtVPsDNIDsQGR |
| P07550 | T393 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ADRB2 ADRB2R B2AR | ENKLLCEDLPGtEDFVGHQGtVPsDNIDsQGRNCstNDsLL |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08195 | T106 | Sugiyama | SLC3A2 MDU1 | SDPPALASKNAEVTGTMsQDtEVDMKEVELNELEPEKQPMN |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P0CAP2 | S365 | Sugiyama | POLR2M GRINL1A | PEGESSGRYREVRDEDDDWssDEF_________________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10696 | S431 | Sugiyama | ALPG ALPPL ALPPL2 | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETH |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11387 | S10 | Sugiyama | TOP1 | ___________MsGDHLHNDsQIEADFRLNDsHKHKDKHKD |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13798 | S185 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | VAEKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQ |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14625 | T522 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMA |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15927 | S257 | Sugiyama | RPA2 REPA2 RPA32 RPA34 | MsVsSIKQAVDFLSNEGHIysTVDDDHFKSTDAE_______ |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17096 | S103 | Sugiyama | HMGA1 HMGIY | PRGRPKKLEKEEEEGIsQEssEEEQ________________ |
| P17812 | S578 | Sugiyama | CTPS1 CTPS | GCRLsPRDtysDRsGsssPDsEItELKFPsINHD_______ |
| P17844 | S519 | Sugiyama | DDX5 G17P1 HELR HLR1 | AGKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAAN |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19338 | T583 | Sugiyama | NCL | sPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTD |
| P20042 | S105 | Sugiyama | EIF2S2 EIF2B | TKKIFDIDEAEEGVKDLKIEsDVQEPtEPEDDLDIMLGNKK |
| P20042 | T33 | Sugiyama | EIF2S2 EIF2B | sKKKKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtEDKD |
| P20810 | S373 | Sugiyama | CAST | LPEPEEKPKPRsEsELIDELsEDFDRsECKEKPSKPTEKTE |
| P21127 | S277 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | APAQKPAQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSA |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P23246 | S521 | Sugiyama | SFPQ PSF | EKQQREQVEKNMKDAKDKLEsEMEDAyHEHQANLLRQDLMR |
| P23396 | S209 | Sugiyama | RPS3 OK/SW-cl.26 | MLPWDPTGKIGPKKPLPDHVsIVEPKDEILPttPIsEQKGG |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23921 | T774 | Sugiyama | RRM1 RR1 | KEKLKDKEKVSKEEEEKERNtAAMVCsLENRDECLMCGS__ |
| P25205 | S704 | Sugiyama | MCM3 | DQEQKRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPK |
| P25205 | S711 | Sugiyama | MCM3 | RRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADsQEt |
| P25205 | T713 | Sugiyama | MCM3 | KTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADsQEtKE |
| P25205 | Y708 | Sugiyama | MCM3 | KRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADs |
| P25705 | T64 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | QKtGtAEMssILEERILGADtsVDLEETGRVLsIGDGIARV |
| P25788 | S250 | Sugiyama | PSMA3 HC8 PSC8 | KDIREEAEKyAKEsLKEEDEsDDDNM_______________ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T66 | PSP | MSN | GLQYQDTKGFSTWLKLNKKVtAQDVRKEsPLLFKFRAKFyP |
| P26196 | S475 | Sugiyama | DDX6 HLR2 RCK | TEIKPIPsNIDKSLyVAEyHsEPVEDEKP____________ |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S189 | Sugiyama | CALR CRTC | THLytLIVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIK |
| P27797 | S193 | Sugiyama | CALR CRTC | tLIVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIKDPDA |
| P27797 | S214 | Sugiyama | CALR CRTC | GsLEDDWDFLPPKKIKDPDAsKPEDWDERAKIDDPtDsKPE |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S71 | Sugiyama | EEF1D EF1D | ARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVEN |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30411 | S366 | SIGNOR|iPTMNet|EPSD | BDKRB2 BKR2 | VyQGVCQKGGCRSEPIQMENsMGTLRTsIsVERQIHKLQDW |
| P30411 | S373 | SIGNOR|iPTMNet|EPSD | BDKRB2 BKR2 | KGGCRSEPIQMENsMGTLRTsIsVERQIHKLQDWAGSRQ__ |
| P30411 | S375 | SIGNOR|iPTMNet|EPSD | BDKRB2 BKR2 | GCRSEPIQMENsMGTLRTsIsVERQIHKLQDWAGSRQ____ |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31327 | T900 | Sugiyama | CPS1 | KMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQISKC |
| P33993 | S314 | Sugiyama | MCM7 CDC47 MCM2 | SETyLEAHRIVKMNKSEDDEsGAGELtREELRQIAEEDFyE |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34947 | S484 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | GRK5 GPRK5 | PFVPDPRAVYCKDVLDIEQFstVKGVNLDHtDDDFYSKFST |
| P34947 | S589 | Sugiyama | GRK5 GPRK5 | SKtsFNHHINSNHVSsNstGss___________________ |
| P34947 | S590 | Sugiyama | GRK5 GPRK5 | KtsFNHHINSNHVSsNstGss____________________ |
| P34947 | T10 | PSP | GRK5 GPRK5 | ___________MELENIVANtVLLKAREGGGGKRKGKSKKW |
| P34947 | T485 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | GRK5 GPRK5 | FVPDPRAVYCKDVLDIEQFstVKGVNLDHtDDDFYSKFSTG |
| P34947 | T494 | Sugiyama | GRK5 GPRK5 | CKDVLDIEQFstVKGVNLDHtDDDFYSKFSTGSVSIPWQNE |
| P35221 | T645 | Sugiyama | CTNNA1 | IRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDDQLIA |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35659 | S227 | Sugiyama | DEK | ERNsSGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDE |
| P35659 | S230 | Sugiyama | DEK | sSGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDEDKE |
| P36578 | S55 | Sugiyama | RPL4 RPL1 | DIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVAR |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37840 | S129 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40925 | T225 | Sugiyama | MDH1 MDHA | KEVGVyEALKDDsWLKGEFVttVQQRGAAVIKARKLssAMS |
| P41227 | S216 | Sugiyama | NAA10 ARD1 ARD1A TE2 | EEKGLAAEDsGGDsKDLsEVsEtTEstDVKDssEAsDsAs_ |
| P43003 | S512 | Sugiyama | SLC1A3 EAAT1 GLAST GLAST1 | GIVEHLSRHELKNRDVEMGNsVIEENEMKKPyQLIAQDNET |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43250 | S484 | Sugiyama | GRK6 GPRK6 | PFKPDPQAIYCKDVLDIEQFstVKGVELEPTDQDFYQKFAT |
| P43250 | T485 | Sugiyama | GRK6 GPRK6 | FKPDPQAIYCKDVLDIEQFstVKGVELEPTDQDFYQKFATG |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49321 | S176 | Sugiyama | NASP | EAKKTEDKSLAKPEtDKEQDsEMEKGGREDMDIsKsAEEPQ |
| P49321 | S497 | Sugiyama | NASP | tEGsEEDDKENDKtEEMPNDsVLENKsLQENEEEEIGNLEL |
| P49321 | T207 | Sugiyama | NASP | DIsKsAEEPQEKVDLtLDWLtEtsEEAKGGAAPEGPNEAEV |
| P49407 | S412 | GPS6|EPSD | ARRB1 ARR1 | ARQRLKGMKDDKEEEEDGtGsPQLNNR______________ |
| P49792 | S2493 | Sugiyama | RANBP2 NUP358 | EEtTRERTDVIQGDDVADAtsEVEVsstSEttPKAVVsPPK |
| P49792 | S2498 | Sugiyama | RANBP2 NUP358 | ERTDVIQGDDVADAtsEVEVsstSEttPKAVVsPPKFVFGs |
| P50502 | S346 | GPS6|SIGNOR|EPSD|PSP | ST13 AAG2 FAM10A1 HIP SNC6 | MQDPEVMVAFQDVAQNPANMsKYQSNPKVMNLISKLSAKFG |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P51858 | T225 | Sugiyama | HDGF HMG1L2 | GsGRGPPQEEEEEEDEEEEAtKEDAEAPGIRDHEsL_____ |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S457 | Sugiyama | ACLY | FLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMPQD |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55060 | S342 | Sugiyama | CSE1L CAS XPO2 | ASVCERPHYKNLFEDQNtLtsICEKVIVPNMEFRAADEEAF |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P55081 | S118 | Sugiyama | MFAP1 | EERLARHRKIVEPEVVGEsDsEVEGDAWRMEREDssEEEEE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62241 | S4 | Sugiyama | RPS8 OK/SW-cl.83 | _________________MGIsRDNWHKRRKTGGKRKPYHKK |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00839 | S59 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QAALDDEEAGGRPAMEPGNGsLDLGGDsAGRSGAGLEQEAA |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q04917 | T31 | Sugiyama | YWHAH YWHA1 | ARLAEQAERyDDMAsAMKAVtELNEPLsNEDRNLLsVAyKN |
| Q05519 | Y425 | Sugiyama | SRSF11 SFRS11 | EKDRERKSEsDKDVKQVtRDyDEEEQGYDsEKEKKEEKKPI |
| Q07021 | S201 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | ALVLDCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKD |
| Q07021 | S213 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | VGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDW |
| Q07021 | S87 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | CGCGCGSLHTDGDKAFVDFLsDEIKEERKIQKHKTLPKMsG |
| Q08945 | S437 | Sugiyama | SSRP1 FACT80 | FVNAKKLNIKNRGLKEGMNPsyDEyADsDEDQHDAYLERMK |
| Q08945 | S444 | Sugiyama | SSRP1 FACT80 | NIKNRGLKEGMNPsyDEyADsDEDQHDAYLERMKEEGKIRE |
| Q08945 | Y438 | Sugiyama | SSRP1 FACT80 | VNAKKLNIKNRGLKEGMNPsyDEyADsDEDQHDAYLERMKE |
| Q12792 | T348 | Sugiyama | TWF1 PTK9 | GPAGKRGIRRLIRGPAEtEAttD__________________ |
| Q12792 | T349 | Sugiyama | TWF1 PTK9 | PAGKRGIRRLIRGPAEtEAttD___________________ |
| Q12874 | S482 | Sugiyama | SF3A3 SAP61 | LKLQKASERWQPDtEEEyEDssGNVVNKKTYEDLKRQGLL_ |
| Q13185 | S176 | Sugiyama | CBX3 | ANMKCPQIVIAFYEERLtWHsCPEDEAQ_____________ |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13283 | T143 | Sugiyama | G3BP1 G3BP | KFyVHNDIFRyQDEVFGGFVtEPQEEsEEEVEEPEERQQtP |
| Q13435 | S289 | Sugiyama | SF3B2 SAP145 | IPQALEKILQLKESRQEEMNsQQEEEEMETDARssLGQsAs |
| Q13435 | S309 | Sugiyama | SF3B2 SAP145 | sQQEEEEMETDARssLGQsAsEtEEDtVsVsKKEKNRKRRN |
| Q13451 | S445 | Sugiyama | FKBP5 AIG6 FKBP51 | ANKAMGKKTSEGVTNEKGtDsQAMEEEKPEGHV________ |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13547 | S423 | Sugiyama | HDAC1 RPD3L1 | KRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAKRV |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14203 | S417 | Sugiyama | DCTN1 | KKNQELEVVRQQRERLQEELsQAEstIDELKEQVDAALGAE |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q15084 | S428 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | EREPWDGRDGELPVEDDIDLsDVELDDLGKDEL________ |
| Q15527 | T195 | Sugiyama | SURF2 | LFTRKDLGstEDGDGtDDFLtDKEDEKAKPPREKATDEGRR |
| Q16143 | S118 | GPS6|SIGNOR|iPTMNet|EPSD | SNCB | VAQEAAEEPLIEPLMEPEGEsYEDPPQEEyQEYEPEA____ |
| Q16513 | S952 | Sugiyama | PKN2 PRK2 PRKCL2 | PFIPTIRGREDVSNFDDEFtsEAPILtPPREPRILsEEEQE |
| Q16513 | T951 | Sugiyama | PKN2 PRK2 PRKCL2 | PPFIPTIRGREDVSNFDDEFtsEAPILtPPREPRILsEEEQ |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5SSJ5 | S446 | Sugiyama | HP1BP3 | KEPDDSRDEDEDEDEssEEDsEDEEPPPKRRLQKKTPAKSP |
| Q5T035 | T62 | Sugiyama | FAM120A2P C9orf129 | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6PKG0 | T769 | Sugiyama | LARP1 KIAA0731 LARP | ALANKLFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtP |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7Z3K3 | S28 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | MECEEEELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQP |
| Q86UE4 | S457 | Sugiyama | MTDH AEG1 LYRIC | LPTGKSKKKKKKKKKQGEDNstAQDtEELEKEIREDLPVNt |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86XZ4 | S166 | Sugiyama | SPATS2 SCR59 SPATA10 Nbla00526 | sLSEGLETLSIDARELEDPEsAMLDTLDRTGSMLQNGVSDF |
| Q8NE71 | S595 | Sugiyama | ABCF1 ABC50 | TKEALTRKQQKCRRKNQDEEsQEAPELLKRPKEYTVRFTFP |
| Q8NEN9 | S496 | Sugiyama | PDZD8 PDZK8 | SGYEEEAAGLTVDTESRELDsEFEDLAsDVRAQNEFKDEAQ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TDU6 | S310 | PSP | GPBAR1 TGR5 | PWRAAAQRCLQGLWGRASRDsPGPSIAYHPSsQssVDLDLN |
| Q8TDU6 | S321 | PSP | GPBAR1 TGR5 | GLWGRASRDsPGPSIAYHPSsQssVDLDLN___________ |
| Q8TDU6 | S323 | PSP | GPBAR1 TGR5 | WGRASRDsPGPSIAYHPSsQssVDLDLN_____________ |
| Q8TDU6 | S324 | PSP | GPBAR1 TGR5 | GRASRDsPGPSIAYHPSsQssVDLDLN______________ |
| Q8WVC0 | S66 | Sugiyama | LEO1 RDL | DQDERGDSGQPSNKELFGDDsEDEGAsHHsGSDNHSERSDN |
| Q8WX92 | S542 | Sugiyama | NELFB COBRA1 KIAA1182 | ALQKALEPTGQSGEAVKELysQLGEKLEQLDHRKPsPAQAA |
| Q92598 | S510 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | FTISTASMVEKVPtEENEMssEADMECLNQRPPENPDTDKN |
| Q92769 | S424 | Sugiyama | HDAC2 | KRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGAKK |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q96EV2 | S41 | Sugiyama | RBM33 PRR8 | FDKPGAERSWRRRAADEDWDsELEDDLLGEDLLsGKKNQSD |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q99575 | T761 | Sugiyama | POP1 KIAA0061 | SEVPCAPMPKKTHQPSDEVGtsIEHPREAEEVMDAGCQESA |
| Q99613 | S154 | Sugiyama | EIF3C EIF3S8 | NAKALSTLRQKIRKyNRDFEsHItSyKQNPEQsADEDAEKN |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q9BQ52 | S215 | Sugiyama | ELAC2 HPC2 | QPWQsPERPLsRLsPERssDsEsNENEPHLPHGVsQRRGVR |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVS4 | S380 | Sugiyama | RIOK2 RIO2 | EEsEGCYCRssGDPEQIKEDsLsEEsADARsFEMTEFNQAL |
| Q9BVS4 | S412 | Sugiyama | RIOK2 RIO2 | EMTEFNQALEEIKGQVVENNsVTEFsEEKNRTENYNRQDGQ |
| Q9BW91 | S343 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | SHSQFIKLVAEKRDAHWSEDsEADCHAL_____________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9H1E3 | S113 | Sugiyama | NUCKS1 NUCKS JC7 | RQAASKAASKQREMLMEDVGsEEEQEEEDEAPFQEKDsGsD |
| Q9H1E3 | S144 | Sugiyama | NUCKS1 NUCKS JC7 | PFQEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPER |
| Q9HCN4 | S338 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | HPsDLILtRGTLDEEDEEADsDtDDIDHRVTEESHEEPAFQ |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NRF8 | S574 | Sugiyama | CTPS2 | YLQQGCKLsssDRysDAsDDsFSEPRIAELEIS________ |
| Q9NXG2 | S88 | Sugiyama | THUMPD1 | YGDDMYGPEKFtDKDQQPsGsEGEDDDAEAALKKEVGDIKA |
| Q9NYL9 | S25 | Sugiyama | TMOD3 | FRKDLEKyKDLDEDELLGNLsEtELKQLETVLDDLDPENAL |
| Q9NZB2 | T413 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q9UBN7 | S22 | PSP | HDAC6 KIAA0901 JM21 | TSTGQDSTTTRQRRsRQNPQsPPQDSSVTSKRNIKKGAVPR |
| Q9UG63 | T35 | Sugiyama | ABCF2 HUSSY-18 | EAAKARQRPRKGHEENGDVVtEPQVAEKNEANGRETTEVDL |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UHD8 | S482 | Sugiyama | SEPTIN9 KIAA0991 MSF SEPT9 | TADLLSNGIDVYPQKEFDEDsEDRLVNEKFREMIPFAVVGS |
| Q9UPR3 | S475 | Sugiyama | SMG5 EST1B KIAA1089 | RLSCLRRRRHPPKVGDDSDLsEGFEsDSSHDSARASEGSDS |
| Q9UPR3 | S480 | Sugiyama | SMG5 EST1B KIAA1089 | RRRRHPPKVGDDSDLsEGFEsDSSHDSARASEGSDSGSDKS |
| Q9UPT8 | S143 | Sugiyama | ZC3H4 C19orf7 KIAA1064 | KSKHKRHAsSSDDFsDFsDDsDFsPSEKGHRKyREysPPyA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9UQ88 | S265 | Sugiyama | CDK11A CDC2L2 CDC2L3 PITSLREB | APAQKPAQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSA |
| Q9Y265 | S434 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | NLLAKINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKY |
| Q9Y2B0 | T79 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGEQIDPs |
| Q9Y3B9 | S67 | Sugiyama | RRP15 KIAA0507 CGI-115 | GSCGsEKDHFYsDDDAIEADsEGDAEPCDKENENDGEssVG |
| Q9Y3F4 | S254 | Sugiyama | STRAP MAWD UNRIP | EKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFS |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.416967e-11 | 10.849 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.066236e-11 | 10.685 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.985074e-10 | 9.223 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.279788e-10 | 9.082 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.081169e-09 | 8.966 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.641140e-08 | 7.578 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.588039e-08 | 7.587 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.222204e-08 | 7.653 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.809979e-08 | 7.551 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.618321e-08 | 7.336 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.281794e-08 | 7.277 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.160562e-08 | 7.088 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.796483e-08 | 7.009 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.131377e-07 | 6.946 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.121537e-07 | 6.950 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.540710e-07 | 6.343 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.888905e-07 | 6.311 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.789704e-06 | 5.747 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.781237e-06 | 5.749 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.014965e-06 | 5.696 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.279927e-06 | 5.642 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.429492e-06 | 5.614 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.446769e-06 | 5.264 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.919527e-06 | 5.101 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.905112e-06 | 5.102 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.908771e-06 | 5.102 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.774545e-06 | 5.109 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.073142e-06 | 5.042 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.764252e-06 | 5.010 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.108069e-05 | 4.955 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.229327e-05 | 4.910 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.505755e-05 | 4.822 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.664695e-05 | 4.779 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.739366e-05 | 4.760 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.739478e-05 | 4.760 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.903763e-05 | 4.720 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.117660e-05 | 4.674 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.185108e-05 | 4.661 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.231927e-05 | 4.651 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.594319e-05 | 4.586 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.594319e-05 | 4.586 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.567828e-05 | 4.590 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.964241e-05 | 4.528 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.215366e-05 | 4.493 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.117518e-05 | 4.385 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.665379e-05 | 4.331 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.091092e-05 | 4.293 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.205272e-05 | 4.284 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.893492e-05 | 4.230 | 1 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.163348e-05 | 4.210 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.589091e-05 | 4.181 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.035752e-05 | 4.095 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.461201e-05 | 4.073 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.078396e-04 | 3.967 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.168017e-04 | 3.933 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.412839e-04 | 3.850 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.498777e-04 | 3.824 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.580505e-04 | 3.801 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.714891e-04 | 3.766 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.801767e-04 | 3.744 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.100709e-04 | 3.678 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.100709e-04 | 3.678 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.033535e-04 | 3.692 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.121578e-04 | 3.673 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.264467e-04 | 3.645 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.324704e-04 | 3.634 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.492130e-04 | 3.603 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.794768e-04 | 3.554 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.848715e-04 | 3.545 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.085286e-04 | 3.511 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.375949e-04 | 3.472 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.633546e-04 | 3.440 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.014168e-04 | 3.396 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.231608e-04 | 3.373 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.222092e-04 | 3.374 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.231608e-04 | 3.373 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.334537e-04 | 3.363 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.892927e-04 | 3.310 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.266376e-04 | 3.278 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.266376e-04 | 3.278 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.539451e-04 | 3.257 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.654172e-04 | 3.248 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.757329e-04 | 3.240 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.077934e-04 | 3.216 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.544030e-04 | 3.184 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.961023e-04 | 3.157 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.961023e-04 | 3.157 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.348393e-04 | 3.134 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.997689e-04 | 3.097 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.210825e-04 | 3.086 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.765642e-04 | 3.057 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.765642e-04 | 3.057 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.366137e-04 | 3.077 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.310360e-04 | 3.080 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.206183e-04 | 3.036 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.399702e-04 | 3.027 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.592907e-04 | 3.018 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.006510e-03 | 2.997 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.058734e-03 | 2.975 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.299115e-03 | 2.886 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.490876e-03 | 2.827 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.510695e-03 | 2.821 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.510695e-03 | 2.821 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.613285e-03 | 2.792 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.656494e-03 | 2.781 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.729776e-03 | 2.762 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.790226e-03 | 2.747 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.959037e-03 | 2.708 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.146178e-03 | 2.668 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.221810e-03 | 2.653 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.267974e-03 | 2.644 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.309643e-03 | 2.636 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.329856e-03 | 2.633 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.344869e-03 | 2.630 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.358003e-03 | 2.627 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.539475e-03 | 2.595 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.497412e-03 | 2.603 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.587393e-03 | 2.587 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.596382e-03 | 2.586 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.658030e-03 | 2.575 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.659162e-03 | 2.575 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.722770e-03 | 2.565 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.004714e-03 | 2.522 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.024049e-03 | 2.519 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.405376e-03 | 2.468 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.529596e-03 | 2.452 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.529596e-03 | 2.452 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.529596e-03 | 2.452 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.529596e-03 | 2.452 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.287401e-03 | 2.483 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.549177e-03 | 2.450 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.314051e-03 | 2.365 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.355004e-03 | 2.361 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.382836e-03 | 2.358 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.631787e-03 | 2.334 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.631787e-03 | 2.334 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.757858e-03 | 2.323 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.782626e-03 | 2.320 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.997582e-03 | 2.301 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.997582e-03 | 2.301 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.347977e-03 | 2.272 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.874029e-03 | 2.312 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.870344e-03 | 2.231 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.870344e-03 | 2.231 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.887847e-03 | 2.230 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.952939e-03 | 2.225 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.952939e-03 | 2.225 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.952939e-03 | 2.225 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.952939e-03 | 2.225 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.373594e-03 | 2.196 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.642653e-03 | 2.178 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.280529e-03 | 2.138 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.993255e-03 | 2.097 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 8.201515e-03 | 2.086 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.622126e-03 | 2.064 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.479943e-03 | 2.023 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.834375e-03 | 2.054 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.375669e-03 | 2.028 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.657824e-03 | 2.015 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.001348e-02 | 1.999 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.047695e-02 | 1.980 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.047695e-02 | 1.980 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.047695e-02 | 1.980 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.047695e-02 | 1.980 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.256024e-02 | 1.901 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.131850e-02 | 1.946 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.157969e-02 | 1.936 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.137607e-02 | 1.944 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.131027e-02 | 1.947 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.126779e-02 | 1.948 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.157969e-02 | 1.936 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.225205e-02 | 1.912 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.236624e-02 | 1.908 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.267788e-02 | 1.897 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.275844e-02 | 1.894 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.275881e-02 | 1.894 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.275881e-02 | 1.894 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.281311e-02 | 1.892 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.283871e-02 | 1.891 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.283871e-02 | 1.891 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.283871e-02 | 1.891 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.332961e-02 | 1.875 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.345092e-02 | 1.871 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.347065e-02 | 1.871 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.366772e-02 | 1.864 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.430760e-02 | 1.844 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.453746e-02 | 1.838 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.555613e-02 | 1.808 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.559739e-02 | 1.807 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.562578e-02 | 1.806 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.596015e-02 | 1.797 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.596015e-02 | 1.797 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.596015e-02 | 1.797 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.798988e-02 | 1.745 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.780509e-02 | 1.749 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.596015e-02 | 1.797 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.798988e-02 | 1.745 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.759449e-02 | 1.755 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.738175e-02 | 1.760 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.813220e-02 | 1.742 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.884660e-02 | 1.725 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.884660e-02 | 1.725 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.887789e-02 | 1.724 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.948556e-02 | 1.710 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.000228e-02 | 1.699 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.041606e-02 | 1.690 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.059242e-02 | 1.686 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.108332e-02 | 1.676 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.108332e-02 | 1.676 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.115917e-02 | 1.675 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.118867e-02 | 1.674 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.126327e-02 | 1.672 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.126327e-02 | 1.672 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.126327e-02 | 1.672 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.126327e-02 | 1.672 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.126327e-02 | 1.672 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.126327e-02 | 1.672 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.148476e-02 | 1.668 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.182521e-02 | 1.661 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.230437e-02 | 1.652 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.328209e-02 | 1.633 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.333049e-02 | 1.632 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.642235e-02 | 1.578 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.642235e-02 | 1.578 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.576317e-02 | 1.589 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.563807e-02 | 1.591 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.372856e-02 | 1.625 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.514781e-02 | 1.599 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.440651e-02 | 1.612 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.646119e-02 | 1.577 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.769722e-02 | 1.558 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.771752e-02 | 1.557 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.771752e-02 | 1.557 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.845799e-02 | 1.546 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.008940e-02 | 1.522 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.008940e-02 | 1.522 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.008940e-02 | 1.522 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.263186e-02 | 1.486 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.263186e-02 | 1.486 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.263186e-02 | 1.486 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.263186e-02 | 1.486 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.296684e-02 | 1.482 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.319455e-02 | 1.479 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.319455e-02 | 1.479 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.335209e-02 | 1.477 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.361563e-02 | 1.473 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.426010e-02 | 1.465 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.458909e-02 | 1.461 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.458909e-02 | 1.461 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.553847e-02 | 1.449 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.553847e-02 | 1.449 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.556940e-02 | 1.449 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.766242e-02 | 1.424 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.766242e-02 | 1.424 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.895282e-02 | 1.409 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.953730e-02 | 1.403 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.410981e-02 | 1.355 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.410981e-02 | 1.355 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.625740e-02 | 1.335 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.625740e-02 | 1.335 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.625740e-02 | 1.335 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.625740e-02 | 1.335 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.434410e-02 | 1.353 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.675115e-02 | 1.330 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.733933e-02 | 1.325 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.548915e-02 | 1.342 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.625740e-02 | 1.335 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.369717e-02 | 1.360 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.451125e-02 | 1.352 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.558074e-02 | 1.341 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.416867e-02 | 1.355 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.618039e-02 | 1.336 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.788962e-02 | 1.320 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.069953e-02 | 1.390 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.548915e-02 | 1.342 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.831445e-02 | 1.316 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.843608e-02 | 1.315 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.063897e-02 | 1.296 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.113068e-02 | 1.291 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.125351e-02 | 1.290 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.232840e-02 | 1.281 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.275145e-02 | 1.278 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.369711e-02 | 1.270 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.396911e-02 | 1.268 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.396911e-02 | 1.268 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.605335e-02 | 1.251 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.605335e-02 | 1.251 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.737569e-02 | 1.241 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.773451e-02 | 1.239 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.059152e-02 | 1.218 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.081582e-02 | 1.216 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.081582e-02 | 1.216 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.081582e-02 | 1.216 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.131208e-02 | 1.212 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.154259e-02 | 1.211 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.224056e-02 | 1.206 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.260259e-02 | 1.203 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.274618e-02 | 1.202 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.274618e-02 | 1.202 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.274618e-02 | 1.202 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.286007e-02 | 1.202 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.286007e-02 | 1.202 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.737486e-02 | 1.172 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.787210e-02 | 1.168 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.831261e-02 | 1.165 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.896976e-02 | 1.161 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.910826e-02 | 1.160 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.910826e-02 | 1.160 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.031248e-02 | 1.153 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.127510e-02 | 1.147 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.246895e-02 | 1.140 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 7.367363e-02 | 1.133 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.449633e-02 | 1.128 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.002166e-02 | 1.097 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.002166e-02 | 1.097 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 8.002166e-02 | 1.097 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.787517e-02 | 1.056 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.721835e-02 | 1.059 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.337365e-02 | 1.079 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.817740e-02 | 1.055 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.817740e-02 | 1.055 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.138814e-02 | 1.089 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.048868e-02 | 1.043 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.314730e-02 | 1.031 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.429103e-02 | 1.026 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.615290e-02 | 1.017 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.120707e-02 | 1.040 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.721835e-02 | 1.059 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.839748e-02 | 1.106 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.846614e-02 | 1.105 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.946182e-02 | 1.048 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.614961e-02 | 1.065 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.545228e-02 | 1.020 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.120707e-02 | 1.040 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.493661e-02 | 1.023 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.432976e-02 | 1.074 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.721835e-02 | 1.059 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.872093e-02 | 1.006 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.911043e-02 | 1.004 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.911043e-02 | 1.004 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.970559e-02 | 1.001 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.975404e-02 | 1.001 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.001517e-01 | 0.999 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.001517e-01 | 0.999 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.009955e-01 | 0.996 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.009955e-01 | 0.996 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.009955e-01 | 0.996 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.014951e-01 | 0.994 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.014951e-01 | 0.994 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.014951e-01 | 0.994 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.047191e-01 | 0.980 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.047191e-01 | 0.980 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.047191e-01 | 0.980 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.050403e-01 | 0.979 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.050403e-01 | 0.979 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.050403e-01 | 0.979 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.050403e-01 | 0.979 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.050403e-01 | 0.979 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.050403e-01 | 0.979 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.050403e-01 | 0.979 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.050403e-01 | 0.979 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.050403e-01 | 0.979 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.050403e-01 | 0.979 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.050403e-01 | 0.979 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.050403e-01 | 0.979 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.050403e-01 | 0.979 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.050403e-01 | 0.979 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.050403e-01 | 0.979 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.050403e-01 | 0.979 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.050403e-01 | 0.979 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.050403e-01 | 0.979 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.050403e-01 | 0.979 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.050403e-01 | 0.979 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.050403e-01 | 0.979 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.050403e-01 | 0.979 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.050403e-01 | 0.979 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.050403e-01 | 0.979 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.050403e-01 | 0.979 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.055121e-01 | 0.977 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.055121e-01 | 0.977 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.072528e-01 | 0.970 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.072528e-01 | 0.970 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.072528e-01 | 0.970 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.094617e-01 | 0.961 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.099237e-01 | 0.959 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.103702e-01 | 0.957 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.103702e-01 | 0.957 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.440001e-01 | 0.842 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.440001e-01 | 0.842 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.249750e-01 | 0.903 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.229061e-01 | 0.910 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.229061e-01 | 0.910 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.229061e-01 | 0.910 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.229061e-01 | 0.910 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.229061e-01 | 0.910 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.157868e-01 | 0.936 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.157868e-01 | 0.936 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.315415e-01 | 0.881 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.204708e-01 | 0.919 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.482012e-01 | 0.829 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.482012e-01 | 0.829 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.482012e-01 | 0.829 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.482012e-01 | 0.829 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.482012e-01 | 0.829 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.473138e-01 | 0.832 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.465067e-01 | 0.834 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.249750e-01 | 0.903 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.217703e-01 | 0.914 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.473138e-01 | 0.832 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.473138e-01 | 0.832 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.187062e-01 | 0.926 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.217703e-01 | 0.914 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.361313e-01 | 0.866 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.473138e-01 | 0.832 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.324313e-01 | 0.878 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.273330e-01 | 0.895 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.244738e-01 | 0.905 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.315415e-01 | 0.881 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.440001e-01 | 0.842 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.423275e-01 | 0.847 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.260988e-01 | 0.899 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.281876e-01 | 0.892 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.296597e-01 | 0.887 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.217703e-01 | 0.914 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.318112e-01 | 0.880 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.473138e-01 | 0.832 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.229061e-01 | 0.910 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.423275e-01 | 0.847 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.139102e-01 | 0.943 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.157868e-01 | 0.936 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.249750e-01 | 0.903 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.315415e-01 | 0.881 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.485180e-01 | 0.828 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.490242e-01 | 0.827 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.501852e-01 | 0.823 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.501852e-01 | 0.823 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.501852e-01 | 0.823 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.501852e-01 | 0.823 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.501852e-01 | 0.823 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.506675e-01 | 0.822 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.511448e-01 | 0.821 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.516465e-01 | 0.819 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.524534e-01 | 0.817 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.537751e-01 | 0.813 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.565587e-01 | 0.805 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.565587e-01 | 0.805 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.609612e-01 | 0.793 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.628558e-01 | 0.788 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.628647e-01 | 0.788 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.628647e-01 | 0.788 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.628647e-01 | 0.788 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.628647e-01 | 0.788 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.628647e-01 | 0.788 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.643416e-01 | 0.784 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.643416e-01 | 0.784 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.643416e-01 | 0.784 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.643416e-01 | 0.784 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.644299e-01 | 0.784 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.657008e-01 | 0.781 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.657008e-01 | 0.781 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.657008e-01 | 0.781 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.683663e-01 | 0.774 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.684574e-01 | 0.774 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.704299e-01 | 0.768 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.707194e-01 | 0.768 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.751541e-01 | 0.757 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.751541e-01 | 0.757 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.768456e-01 | 0.752 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.768456e-01 | 0.752 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.768456e-01 | 0.752 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.776120e-01 | 0.751 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.785314e-01 | 0.748 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.802952e-01 | 0.744 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.825987e-01 | 0.739 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.825987e-01 | 0.739 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.825987e-01 | 0.739 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.828805e-01 | 0.738 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.828805e-01 | 0.738 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.828805e-01 | 0.738 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.828805e-01 | 0.738 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.829188e-01 | 0.738 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.839696e-01 | 0.735 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.839696e-01 | 0.735 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.839696e-01 | 0.735 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.839696e-01 | 0.735 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.843919e-01 | 0.734 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.843919e-01 | 0.734 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.843919e-01 | 0.734 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.877833e-01 | 0.726 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.990526e-01 | 0.701 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.990526e-01 | 0.701 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.831942e-01 | 0.548 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.831942e-01 | 0.548 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 2.831942e-01 | 0.548 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.831942e-01 | 0.548 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.831942e-01 | 0.548 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.831942e-01 | 0.548 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.831942e-01 | 0.548 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.831942e-01 | 0.548 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.831942e-01 | 0.548 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.831942e-01 | 0.548 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.230410e-01 | 0.652 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.585010e-01 | 0.446 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.585010e-01 | 0.446 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.585010e-01 | 0.446 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.585010e-01 | 0.446 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.585010e-01 | 0.446 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.585010e-01 | 0.446 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.585010e-01 | 0.446 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.585010e-01 | 0.446 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.637841e-01 | 0.579 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.637841e-01 | 0.579 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.637841e-01 | 0.579 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.046796e-01 | 0.689 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.334206e-01 | 0.632 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.334206e-01 | 0.632 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.334206e-01 | 0.632 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.334206e-01 | 0.632 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.045447e-01 | 0.516 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.045447e-01 | 0.516 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.045447e-01 | 0.516 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.259000e-01 | 0.371 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.259000e-01 | 0.371 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.259000e-01 | 0.371 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.259000e-01 | 0.371 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.259000e-01 | 0.371 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.259000e-01 | 0.371 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.259000e-01 | 0.371 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.067792e-01 | 0.684 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.628163e-01 | 0.580 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.628163e-01 | 0.580 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.628163e-01 | 0.580 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.628163e-01 | 0.580 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.628163e-01 | 0.580 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.628163e-01 | 0.580 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.298950e-01 | 0.638 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.448698e-01 | 0.462 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.448698e-01 | 0.462 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.448698e-01 | 0.462 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.448698e-01 | 0.462 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.448698e-01 | 0.462 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.225135e-01 | 0.653 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.968374e-01 | 0.706 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.426316e-01 | 0.615 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.777907e-01 | 0.556 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.777907e-01 | 0.556 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.777907e-01 | 0.556 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.226508e-01 | 0.491 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.226508e-01 | 0.491 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.226508e-01 | 0.491 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.844013e-01 | 0.415 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.844013e-01 | 0.415 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.862213e-01 | 0.313 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.862213e-01 | 0.313 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.862213e-01 | 0.313 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.862213e-01 | 0.313 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.862213e-01 | 0.313 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.862213e-01 | 0.313 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.862213e-01 | 0.313 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.862213e-01 | 0.313 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.862213e-01 | 0.313 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.862213e-01 | 0.313 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.632071e-01 | 0.580 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 3.526776e-01 | 0.453 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.526776e-01 | 0.453 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.526776e-01 | 0.453 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.526776e-01 | 0.453 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.103627e-01 | 0.677 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.841598e-01 | 0.546 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.367032e-01 | 0.626 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.270691e-01 | 0.485 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.228611e-01 | 0.374 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.228611e-01 | 0.374 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.228611e-01 | 0.374 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.396342e-01 | 0.620 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.698190e-01 | 0.569 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.547619e-01 | 0.594 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.519326e-01 | 0.454 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.410778e-01 | 0.618 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.410778e-01 | 0.618 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.055175e-01 | 0.515 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.055175e-01 | 0.515 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.868223e-01 | 0.542 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.768017e-01 | 0.424 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.120726e-01 | 0.385 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.120726e-01 | 0.385 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.600381e-01 | 0.337 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.600381e-01 | 0.337 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.600381e-01 | 0.337 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.600381e-01 | 0.337 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.600381e-01 | 0.337 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.402078e-01 | 0.267 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.402078e-01 | 0.267 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.402078e-01 | 0.267 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.402078e-01 | 0.267 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.440230e-01 | 0.463 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.701913e-01 | 0.432 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 4.411499e-01 | 0.355 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.340657e-01 | 0.476 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.261697e-01 | 0.370 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.957774e-01 | 0.305 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.957774e-01 | 0.305 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.957774e-01 | 0.305 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.957774e-01 | 0.305 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.442504e-01 | 0.463 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.135223e-01 | 0.384 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.668991e-01 | 0.435 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.696517e-01 | 0.328 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.696517e-01 | 0.328 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.696517e-01 | 0.328 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.661271e-01 | 0.436 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.165524e-01 | 0.380 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.299708e-01 | 0.276 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.299708e-01 | 0.276 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.299708e-01 | 0.276 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.299708e-01 | 0.276 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.459172e-01 | 0.351 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.495771e-01 | 0.347 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.635678e-01 | 0.334 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.245488e-01 | 0.280 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.245488e-01 | 0.280 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.982949e-01 | 0.303 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.211614e-01 | 0.283 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.211614e-01 | 0.283 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.625485e-01 | 0.250 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.984446e-01 | 0.302 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 5.507943e-01 | 0.259 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.156134e-01 | 0.288 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.156134e-01 | 0.288 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.437504e-01 | 0.265 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.437504e-01 | 0.265 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.353538e-01 | 0.271 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.353538e-01 | 0.271 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.325674e-01 | 0.274 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.492826e-01 | 0.260 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.533908e-01 | 0.257 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.533908e-01 | 0.257 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.657370e-01 | 0.247 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.657370e-01 | 0.247 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.672464e-01 | 0.435 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.550134e-01 | 0.342 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.343162e-01 | 0.630 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.963506e-01 | 0.707 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.314843e-01 | 0.635 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.218916e-01 | 0.375 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.459172e-01 | 0.351 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.507943e-01 | 0.259 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.744785e-01 | 0.324 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.810868e-01 | 0.318 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.048553e-01 | 0.516 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.965124e-01 | 0.707 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.218916e-01 | 0.375 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.774726e-01 | 0.321 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.840355e-01 | 0.315 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.334206e-01 | 0.632 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.067792e-01 | 0.684 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.672464e-01 | 0.435 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.353538e-01 | 0.271 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.110518e-01 | 0.386 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.139179e-01 | 0.670 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.228611e-01 | 0.374 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.957774e-01 | 0.305 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.507943e-01 | 0.259 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.023174e-01 | 0.520 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.841598e-01 | 0.546 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.844013e-01 | 0.415 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.415094e-01 | 0.617 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.169949e-01 | 0.664 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.392615e-01 | 0.621 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.045447e-01 | 0.516 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.045447e-01 | 0.516 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.494827e-01 | 0.603 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.228611e-01 | 0.374 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.024414e-01 | 0.395 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.218916e-01 | 0.375 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.055175e-01 | 0.515 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.988917e-01 | 0.524 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.135134e-01 | 0.289 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.135134e-01 | 0.289 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.440230e-01 | 0.463 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.659828e-01 | 0.332 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.440230e-01 | 0.463 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.652076e-01 | 0.332 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.334206e-01 | 0.632 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.862213e-01 | 0.313 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.632071e-01 | 0.580 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.485002e-01 | 0.458 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.402078e-01 | 0.267 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.402078e-01 | 0.267 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.299708e-01 | 0.276 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.211614e-01 | 0.283 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.144705e-01 | 0.289 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.768017e-01 | 0.424 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.334206e-01 | 0.632 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.777907e-01 | 0.556 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.632071e-01 | 0.580 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.054108e-01 | 0.515 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.299708e-01 | 0.276 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.108014e-01 | 0.292 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.170145e-01 | 0.286 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.170145e-01 | 0.286 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.645286e-01 | 0.578 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.135223e-01 | 0.384 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.426784e-01 | 0.465 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.963082e-01 | 0.402 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.083342e-01 | 0.389 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.298950e-01 | 0.638 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.777907e-01 | 0.556 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.600381e-01 | 0.337 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.402078e-01 | 0.267 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.402078e-01 | 0.267 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.215140e-01 | 0.493 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.178231e-01 | 0.498 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.957774e-01 | 0.305 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.957774e-01 | 0.305 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.696517e-01 | 0.328 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.299708e-01 | 0.276 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.522902e-01 | 0.258 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.898602e-01 | 0.722 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.818627e-01 | 0.550 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.861896e-01 | 0.313 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.679381e-01 | 0.330 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.251734e-01 | 0.371 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.861896e-01 | 0.313 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.844013e-01 | 0.415 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.984446e-01 | 0.302 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.625485e-01 | 0.250 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.773487e-01 | 0.321 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.448698e-01 | 0.462 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.844013e-01 | 0.415 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.999880e-01 | 0.398 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.008101e-01 | 0.697 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.212590e-01 | 0.655 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.565242e-01 | 0.341 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.285250e-01 | 0.483 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.103627e-01 | 0.677 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.593931e-01 | 0.338 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.007046e-01 | 0.397 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.924981e-01 | 0.406 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.957317e-01 | 0.529 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.744785e-01 | 0.324 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.783582e-01 | 0.555 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.448698e-01 | 0.462 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.528162e-01 | 0.344 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.905430e-01 | 0.408 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.060624e-01 | 0.391 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.853460e-01 | 0.545 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.844013e-01 | 0.415 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.054108e-01 | 0.515 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.841010e-01 | 0.547 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.553994e-01 | 0.342 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.522666e-01 | 0.598 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.877254e-01 | 0.312 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.964618e-01 | 0.402 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.111150e-01 | 0.386 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.547307e-01 | 0.594 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.990526e-01 | 0.701 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.990526e-01 | 0.701 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.990526e-01 | 0.701 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.831942e-01 | 0.548 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.230410e-01 | 0.652 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.585010e-01 | 0.446 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.585010e-01 | 0.446 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.585010e-01 | 0.446 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.585010e-01 | 0.446 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.046796e-01 | 0.689 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 4.259000e-01 | 0.371 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.448698e-01 | 0.462 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.448698e-01 | 0.462 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.926318e-01 | 0.534 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.426316e-01 | 0.615 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.426316e-01 | 0.615 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.206721e-01 | 0.656 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.206721e-01 | 0.656 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.228611e-01 | 0.374 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.825366e-01 | 0.417 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.698190e-01 | 0.569 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.698190e-01 | 0.569 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.402078e-01 | 0.267 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.402078e-01 | 0.267 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.261697e-01 | 0.370 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.957774e-01 | 0.305 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.103485e-01 | 0.387 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.715500e-01 | 0.430 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.563701e-01 | 0.341 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.299708e-01 | 0.276 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.299708e-01 | 0.276 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.589080e-01 | 0.338 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.211614e-01 | 0.283 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.575574e-01 | 0.340 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.303134e-01 | 0.275 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.432027e-01 | 0.265 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.868223e-01 | 0.542 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.547307e-01 | 0.594 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.984446e-01 | 0.302 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.256746e-01 | 0.371 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.226508e-01 | 0.491 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.507943e-01 | 0.259 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.592928e-01 | 0.445 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.822829e-01 | 0.317 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.771490e-01 | 0.557 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.777907e-01 | 0.556 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.494827e-01 | 0.603 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.299708e-01 | 0.276 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.844526e-01 | 0.415 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.443002e-01 | 0.463 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.226508e-01 | 0.491 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.228611e-01 | 0.374 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.211614e-01 | 0.283 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.519326e-01 | 0.454 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.696517e-01 | 0.328 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.245488e-01 | 0.280 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.681887e-01 | 0.572 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.681887e-01 | 0.572 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.459615e-01 | 0.263 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.440230e-01 | 0.463 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.230410e-01 | 0.652 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.045447e-01 | 0.516 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.862213e-01 | 0.313 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.402078e-01 | 0.267 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.299708e-01 | 0.276 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.299708e-01 | 0.276 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.299708e-01 | 0.276 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.264298e-01 | 0.279 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.504949e-01 | 0.346 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.410778e-01 | 0.618 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.744785e-01 | 0.324 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.165524e-01 | 0.380 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.818319e-01 | 0.418 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.657079e-01 | 0.576 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.763409e-01 | 0.424 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.144705e-01 | 0.289 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.281310e-01 | 0.368 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.831942e-01 | 0.548 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.448698e-01 | 0.462 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.862213e-01 | 0.313 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.862213e-01 | 0.313 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.050450e-01 | 0.688 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.411499e-01 | 0.355 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.067711e-01 | 0.391 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.597119e-01 | 0.586 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.701913e-01 | 0.432 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.768017e-01 | 0.424 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.577870e-01 | 0.254 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.174364e-01 | 0.663 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.270691e-01 | 0.485 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.411499e-01 | 0.355 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.257712e-01 | 0.371 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.245488e-01 | 0.280 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.999880e-01 | 0.398 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.098463e-01 | 0.293 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.696517e-01 | 0.328 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.326708e-01 | 0.274 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.448698e-01 | 0.462 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.701913e-01 | 0.432 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.350357e-01 | 0.361 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.211614e-01 | 0.283 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.526776e-01 | 0.453 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.183959e-01 | 0.661 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.015777e-01 | 0.396 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.795475e-01 | 0.319 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.530989e-01 | 0.597 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.563701e-01 | 0.341 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.045447e-01 | 0.516 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.519326e-01 | 0.454 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.825366e-01 | 0.417 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.270357e-01 | 0.485 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.632071e-01 | 0.580 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.442132e-01 | 0.612 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.844013e-01 | 0.415 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.015777e-01 | 0.396 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.980537e-01 | 0.303 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.265523e-01 | 0.279 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.045447e-01 | 0.516 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.448698e-01 | 0.462 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.844013e-01 | 0.415 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.829480e-01 | 0.417 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 4.696517e-01 | 0.328 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.299708e-01 | 0.276 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 5.245488e-01 | 0.280 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.228611e-01 | 0.374 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.625485e-01 | 0.250 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.744785e-01 | 0.324 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.924981e-01 | 0.406 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.299708e-01 | 0.276 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.627841e-01 | 0.335 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.402078e-01 | 0.267 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.013981e-01 | 0.396 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.657370e-01 | 0.247 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.270691e-01 | 0.485 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.613960e-01 | 0.251 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.228611e-01 | 0.374 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.625485e-01 | 0.250 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.299708e-01 | 0.276 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.657765e-01 | 0.247 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.657765e-01 | 0.247 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.657765e-01 | 0.247 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.710995e-01 | 0.243 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.710995e-01 | 0.243 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.721769e-01 | 0.242 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.721769e-01 | 0.242 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.761621e-01 | 0.239 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.761621e-01 | 0.239 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.779641e-01 | 0.238 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.779641e-01 | 0.238 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.819344e-01 | 0.235 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.872025e-01 | 0.231 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.885244e-01 | 0.230 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.885244e-01 | 0.230 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.885244e-01 | 0.230 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.885244e-01 | 0.230 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.885244e-01 | 0.230 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.885244e-01 | 0.230 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.885244e-01 | 0.230 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.885244e-01 | 0.230 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.885244e-01 | 0.230 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 5.885244e-01 | 0.230 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.885244e-01 | 0.230 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.885244e-01 | 0.230 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.885244e-01 | 0.230 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.885244e-01 | 0.230 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.885244e-01 | 0.230 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.885244e-01 | 0.230 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.885244e-01 | 0.230 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.885244e-01 | 0.230 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.885244e-01 | 0.230 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.885244e-01 | 0.230 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.885244e-01 | 0.230 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.891202e-01 | 0.230 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.915558e-01 | 0.228 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.934726e-01 | 0.227 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.934726e-01 | 0.227 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.934726e-01 | 0.227 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.934726e-01 | 0.227 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.934726e-01 | 0.227 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.934726e-01 | 0.227 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.968094e-01 | 0.224 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.968094e-01 | 0.224 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.968094e-01 | 0.224 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.977845e-01 | 0.223 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.977845e-01 | 0.223 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.006116e-01 | 0.221 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.006116e-01 | 0.221 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.006116e-01 | 0.221 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.006116e-01 | 0.221 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.006116e-01 | 0.221 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.006116e-01 | 0.221 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.006116e-01 | 0.221 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.062504e-01 | 0.217 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.133432e-01 | 0.212 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 6.133432e-01 | 0.212 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.141415e-01 | 0.212 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.141415e-01 | 0.212 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.209923e-01 | 0.207 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.227308e-01 | 0.206 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.227308e-01 | 0.206 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.227308e-01 | 0.206 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.227308e-01 | 0.206 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.227308e-01 | 0.206 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.227308e-01 | 0.206 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.227308e-01 | 0.206 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.227308e-01 | 0.206 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.227308e-01 | 0.206 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.227308e-01 | 0.206 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.227308e-01 | 0.206 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.241134e-01 | 0.205 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.241134e-01 | 0.205 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.241134e-01 | 0.205 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.241134e-01 | 0.205 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.275257e-01 | 0.202 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.281375e-01 | 0.202 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.281375e-01 | 0.202 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.285717e-01 | 0.202 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.285717e-01 | 0.202 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.285717e-01 | 0.202 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.285717e-01 | 0.202 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.285717e-01 | 0.202 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.317662e-01 | 0.199 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.317662e-01 | 0.199 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.317662e-01 | 0.199 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.317662e-01 | 0.199 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.317662e-01 | 0.199 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.317662e-01 | 0.199 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.317662e-01 | 0.199 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.317662e-01 | 0.199 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.317662e-01 | 0.199 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.317662e-01 | 0.199 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.317662e-01 | 0.199 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.317662e-01 | 0.199 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.317662e-01 | 0.199 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.317662e-01 | 0.199 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.330368e-01 | 0.199 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.348027e-01 | 0.197 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.357988e-01 | 0.197 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.407527e-01 | 0.193 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.434575e-01 | 0.191 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.441383e-01 | 0.191 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.463944e-01 | 0.190 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.463944e-01 | 0.190 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.466487e-01 | 0.189 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.466487e-01 | 0.189 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.476029e-01 | 0.189 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.486381e-01 | 0.188 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.503317e-01 | 0.187 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.503317e-01 | 0.187 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.503317e-01 | 0.187 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.503317e-01 | 0.187 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.503317e-01 | 0.187 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.503317e-01 | 0.187 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.503317e-01 | 0.187 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.503317e-01 | 0.187 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.503317e-01 | 0.187 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.503317e-01 | 0.187 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.503317e-01 | 0.187 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.503317e-01 | 0.187 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.503317e-01 | 0.187 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.539904e-01 | 0.184 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.579896e-01 | 0.182 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.581716e-01 | 0.182 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.594388e-01 | 0.181 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.621669e-01 | 0.179 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.623561e-01 | 0.179 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.663803e-01 | 0.176 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.663803e-01 | 0.176 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.672002e-01 | 0.176 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.672002e-01 | 0.176 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.681875e-01 | 0.175 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.682073e-01 | 0.175 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.682073e-01 | 0.175 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.682073e-01 | 0.175 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.682073e-01 | 0.175 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.682073e-01 | 0.175 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.704660e-01 | 0.174 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.704660e-01 | 0.174 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.704660e-01 | 0.174 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.704660e-01 | 0.174 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.704660e-01 | 0.174 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.704660e-01 | 0.174 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.704660e-01 | 0.174 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.704660e-01 | 0.174 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.704660e-01 | 0.174 | 0 | 0 |
| Opsins | R-HSA-419771 | 6.704660e-01 | 0.174 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.704660e-01 | 0.174 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.704660e-01 | 0.174 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.704660e-01 | 0.174 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.704660e-01 | 0.174 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.704660e-01 | 0.174 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.718085e-01 | 0.173 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.721585e-01 | 0.173 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.763006e-01 | 0.170 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.763006e-01 | 0.170 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.763006e-01 | 0.170 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.763006e-01 | 0.170 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.763006e-01 | 0.170 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.763006e-01 | 0.170 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.763006e-01 | 0.170 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.763006e-01 | 0.170 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.763006e-01 | 0.170 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.834783e-01 | 0.165 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.842268e-01 | 0.165 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.844607e-01 | 0.165 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.844607e-01 | 0.165 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.844607e-01 | 0.165 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.871065e-01 | 0.163 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.887871e-01 | 0.162 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.887871e-01 | 0.162 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.887871e-01 | 0.162 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.892262e-01 | 0.162 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.898026e-01 | 0.161 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.969079e-01 | 0.157 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.976852e-01 | 0.156 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.992108e-01 | 0.155 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.992108e-01 | 0.155 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.006754e-01 | 0.154 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.006754e-01 | 0.154 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.006754e-01 | 0.154 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.006754e-01 | 0.154 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.006754e-01 | 0.154 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.006754e-01 | 0.154 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.010482e-01 | 0.154 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.018396e-01 | 0.154 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 7.018396e-01 | 0.154 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.051007e-01 | 0.152 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.051007e-01 | 0.152 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.051007e-01 | 0.152 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.051007e-01 | 0.152 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.051007e-01 | 0.152 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.051007e-01 | 0.152 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.051007e-01 | 0.152 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.051007e-01 | 0.152 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.051007e-01 | 0.152 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.051007e-01 | 0.152 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.051007e-01 | 0.152 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.083927e-01 | 0.150 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.083927e-01 | 0.150 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.083927e-01 | 0.150 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.083927e-01 | 0.150 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.083927e-01 | 0.150 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.083927e-01 | 0.150 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.088161e-01 | 0.149 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.126822e-01 | 0.147 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.130756e-01 | 0.147 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.130756e-01 | 0.147 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.130756e-01 | 0.147 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.143938e-01 | 0.146 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.185163e-01 | 0.144 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.235045e-01 | 0.141 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.235045e-01 | 0.141 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.235045e-01 | 0.141 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.235045e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.235045e-01 | 0.141 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.235045e-01 | 0.141 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 7.250725e-01 | 0.140 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.255996e-01 | 0.139 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.270350e-01 | 0.138 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.318865e-01 | 0.136 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.360970e-01 | 0.133 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.360970e-01 | 0.133 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.360970e-01 | 0.133 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.360970e-01 | 0.133 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.360970e-01 | 0.133 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.360970e-01 | 0.133 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.360970e-01 | 0.133 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.360970e-01 | 0.133 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.360970e-01 | 0.133 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.360970e-01 | 0.133 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.360970e-01 | 0.133 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.360970e-01 | 0.133 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.360970e-01 | 0.133 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.360970e-01 | 0.133 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.360970e-01 | 0.133 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.360970e-01 | 0.133 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.365400e-01 | 0.133 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.431084e-01 | 0.129 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.431084e-01 | 0.129 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.447293e-01 | 0.128 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.447293e-01 | 0.128 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.447293e-01 | 0.128 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.447293e-01 | 0.128 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.448433e-01 | 0.128 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.448433e-01 | 0.128 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.448433e-01 | 0.128 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.448433e-01 | 0.128 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.448433e-01 | 0.128 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.448433e-01 | 0.128 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.448433e-01 | 0.128 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.477658e-01 | 0.126 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.497781e-01 | 0.125 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.499794e-01 | 0.125 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.535428e-01 | 0.123 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.578684e-01 | 0.120 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.614957e-01 | 0.118 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.638370e-01 | 0.117 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.638370e-01 | 0.117 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.638370e-01 | 0.117 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.638370e-01 | 0.117 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.638370e-01 | 0.117 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.638370e-01 | 0.117 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.638370e-01 | 0.117 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.638370e-01 | 0.117 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.638370e-01 | 0.117 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.641824e-01 | 0.117 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.643779e-01 | 0.117 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.643779e-01 | 0.117 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.647529e-01 | 0.116 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.647529e-01 | 0.116 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.667965e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.667965e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.667965e-01 | 0.115 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.696372e-01 | 0.114 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.728727e-01 | 0.112 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.755108e-01 | 0.110 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.758942e-01 | 0.110 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.761386e-01 | 0.110 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.773575e-01 | 0.109 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.773575e-01 | 0.109 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.773575e-01 | 0.109 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.773747e-01 | 0.109 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.777011e-01 | 0.109 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.783045e-01 | 0.109 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.826194e-01 | 0.106 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.832980e-01 | 0.106 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.832980e-01 | 0.106 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.832980e-01 | 0.106 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.832980e-01 | 0.106 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.832980e-01 | 0.106 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.832980e-01 | 0.106 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.832980e-01 | 0.106 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.842337e-01 | 0.106 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.868306e-01 | 0.104 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 7.886626e-01 | 0.103 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.886626e-01 | 0.103 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.886626e-01 | 0.103 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.886626e-01 | 0.103 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.886626e-01 | 0.103 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.886626e-01 | 0.103 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.886626e-01 | 0.103 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.886626e-01 | 0.103 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.886626e-01 | 0.103 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.886626e-01 | 0.103 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.892934e-01 | 0.103 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.915711e-01 | 0.102 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.915711e-01 | 0.102 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.915711e-01 | 0.102 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.915711e-01 | 0.102 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.923408e-01 | 0.101 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.940253e-01 | 0.100 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.940253e-01 | 0.100 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.940253e-01 | 0.100 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.005452e-01 | 0.097 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.048541e-01 | 0.094 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.054375e-01 | 0.094 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.064741e-01 | 0.093 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.064741e-01 | 0.093 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.084678e-01 | 0.092 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.108798e-01 | 0.091 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.108798e-01 | 0.091 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.108798e-01 | 0.091 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.108798e-01 | 0.091 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.108798e-01 | 0.091 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.108798e-01 | 0.091 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.108798e-01 | 0.091 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.108798e-01 | 0.091 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.108798e-01 | 0.091 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.108798e-01 | 0.091 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.161864e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.165626e-01 | 0.088 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.165626e-01 | 0.088 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.165626e-01 | 0.088 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.165626e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.166903e-01 | 0.088 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.169503e-01 | 0.088 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.184658e-01 | 0.087 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.192774e-01 | 0.087 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.197875e-01 | 0.086 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.217116e-01 | 0.085 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.239223e-01 | 0.084 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.275694e-01 | 0.082 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.285543e-01 | 0.082 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.305558e-01 | 0.081 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.307625e-01 | 0.081 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.307625e-01 | 0.081 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.307625e-01 | 0.081 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.307625e-01 | 0.081 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.307625e-01 | 0.081 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.307625e-01 | 0.081 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.307625e-01 | 0.081 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.307625e-01 | 0.081 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.307625e-01 | 0.081 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.307625e-01 | 0.081 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.307625e-01 | 0.081 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.307625e-01 | 0.081 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.307625e-01 | 0.081 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.307625e-01 | 0.081 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.314180e-01 | 0.080 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.314180e-01 | 0.080 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.323124e-01 | 0.080 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.323124e-01 | 0.080 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.323124e-01 | 0.080 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.323124e-01 | 0.080 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.337813e-01 | 0.079 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.363449e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.383607e-01 | 0.077 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.390755e-01 | 0.076 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.390755e-01 | 0.076 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.429686e-01 | 0.074 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.440811e-01 | 0.074 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.440811e-01 | 0.074 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.451786e-01 | 0.073 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.451786e-01 | 0.073 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.451786e-01 | 0.073 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.485560e-01 | 0.071 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.485560e-01 | 0.071 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.485560e-01 | 0.071 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.485560e-01 | 0.071 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.485560e-01 | 0.071 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.485560e-01 | 0.071 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.485560e-01 | 0.071 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.485560e-01 | 0.071 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.485560e-01 | 0.071 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.485560e-01 | 0.071 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.485560e-01 | 0.071 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.485798e-01 | 0.071 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.485798e-01 | 0.071 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.494248e-01 | 0.071 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.494248e-01 | 0.071 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.494248e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.520483e-01 | 0.070 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.524058e-01 | 0.069 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.550871e-01 | 0.068 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.550871e-01 | 0.068 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.551263e-01 | 0.068 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.579103e-01 | 0.067 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.579103e-01 | 0.067 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.579103e-01 | 0.067 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.592042e-01 | 0.066 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.615824e-01 | 0.065 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.623852e-01 | 0.064 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.636788e-01 | 0.064 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.644796e-01 | 0.063 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.644796e-01 | 0.063 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.644796e-01 | 0.063 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.644796e-01 | 0.063 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.644796e-01 | 0.063 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.644796e-01 | 0.063 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.644796e-01 | 0.063 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.644796e-01 | 0.063 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.644796e-01 | 0.063 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.644796e-01 | 0.063 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.644796e-01 | 0.063 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.644796e-01 | 0.063 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.654809e-01 | 0.063 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.670824e-01 | 0.062 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.673824e-01 | 0.062 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.696774e-01 | 0.061 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.696774e-01 | 0.061 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.696774e-01 | 0.061 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.696774e-01 | 0.061 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.697808e-01 | 0.061 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.719937e-01 | 0.059 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.720140e-01 | 0.059 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.751778e-01 | 0.058 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.751778e-01 | 0.058 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.751778e-01 | 0.058 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.760072e-01 | 0.057 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.760072e-01 | 0.057 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.773059e-01 | 0.057 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.779785e-01 | 0.057 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.787298e-01 | 0.056 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.787298e-01 | 0.056 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.787298e-01 | 0.056 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.787298e-01 | 0.056 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.787298e-01 | 0.056 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.787298e-01 | 0.056 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.787298e-01 | 0.056 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.787298e-01 | 0.056 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.795144e-01 | 0.056 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.805419e-01 | 0.055 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.805419e-01 | 0.055 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.805419e-01 | 0.055 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.811517e-01 | 0.055 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.842496e-01 | 0.053 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.852788e-01 | 0.053 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.853216e-01 | 0.053 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.861452e-01 | 0.052 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.861452e-01 | 0.052 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.861452e-01 | 0.052 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.868260e-01 | 0.052 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.914823e-01 | 0.050 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.914823e-01 | 0.050 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.914823e-01 | 0.050 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.918079e-01 | 0.050 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.927282e-01 | 0.049 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.927282e-01 | 0.049 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.927282e-01 | 0.049 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.937532e-01 | 0.049 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.976254e-01 | 0.047 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.990253e-01 | 0.046 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.990253e-01 | 0.046 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.995687e-01 | 0.046 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.997992e-01 | 0.046 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.997992e-01 | 0.046 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.997992e-01 | 0.046 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.006451e-01 | 0.045 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.006451e-01 | 0.045 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.006451e-01 | 0.045 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.006451e-01 | 0.045 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.006451e-01 | 0.045 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.019176e-01 | 0.045 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.028944e-01 | 0.044 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.028944e-01 | 0.044 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.028944e-01 | 0.044 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.028944e-01 | 0.044 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.028944e-01 | 0.044 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.028944e-01 | 0.044 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.028944e-01 | 0.044 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.055970e-01 | 0.043 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.080308e-01 | 0.042 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.083034e-01 | 0.042 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.083034e-01 | 0.042 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.083034e-01 | 0.042 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.100594e-01 | 0.041 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.105781e-01 | 0.041 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.118269e-01 | 0.040 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.131070e-01 | 0.039 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.131070e-01 | 0.039 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.131070e-01 | 0.039 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.131070e-01 | 0.039 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.131070e-01 | 0.039 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.161279e-01 | 0.038 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.161279e-01 | 0.038 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.181895e-01 | 0.037 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.213269e-01 | 0.036 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.214568e-01 | 0.036 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.222461e-01 | 0.035 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.222461e-01 | 0.035 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.222461e-01 | 0.035 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.222461e-01 | 0.035 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.222461e-01 | 0.035 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.222461e-01 | 0.035 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.233214e-01 | 0.035 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.272937e-01 | 0.033 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.279606e-01 | 0.032 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.304244e-01 | 0.031 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.304244e-01 | 0.031 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.304244e-01 | 0.031 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.304244e-01 | 0.031 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.304244e-01 | 0.031 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.304244e-01 | 0.031 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.304244e-01 | 0.031 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.327163e-01 | 0.030 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.328423e-01 | 0.030 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.328423e-01 | 0.030 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.328423e-01 | 0.030 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.328423e-01 | 0.030 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.335334e-01 | 0.030 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.341856e-01 | 0.030 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.359976e-01 | 0.029 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.359976e-01 | 0.029 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.359976e-01 | 0.029 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.370918e-01 | 0.028 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.377430e-01 | 0.028 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.377430e-01 | 0.028 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.377430e-01 | 0.028 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.377430e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.377430e-01 | 0.028 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.377430e-01 | 0.028 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.379981e-01 | 0.028 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.379981e-01 | 0.028 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.379981e-01 | 0.028 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.386580e-01 | 0.027 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.386580e-01 | 0.027 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.399432e-01 | 0.027 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.412102e-01 | 0.026 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.415644e-01 | 0.026 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.415644e-01 | 0.026 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.415644e-01 | 0.026 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.415644e-01 | 0.026 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.415644e-01 | 0.026 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.415644e-01 | 0.026 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.429190e-01 | 0.026 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.429190e-01 | 0.026 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.429885e-01 | 0.025 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.442921e-01 | 0.025 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.442921e-01 | 0.025 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.442921e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.442921e-01 | 0.025 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.455155e-01 | 0.024 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.466687e-01 | 0.024 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.466687e-01 | 0.024 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.493712e-01 | 0.023 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.501526e-01 | 0.022 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.501526e-01 | 0.022 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.501526e-01 | 0.022 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.501526e-01 | 0.022 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.501526e-01 | 0.022 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.501526e-01 | 0.022 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.504498e-01 | 0.022 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.504498e-01 | 0.022 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.507627e-01 | 0.022 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.513461e-01 | 0.022 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.513461e-01 | 0.022 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.513461e-01 | 0.022 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.513461e-01 | 0.022 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.521467e-01 | 0.021 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.536556e-01 | 0.021 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.548305e-01 | 0.020 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.551654e-01 | 0.020 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.553969e-01 | 0.020 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.553969e-01 | 0.020 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.553969e-01 | 0.020 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.553969e-01 | 0.020 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.553969e-01 | 0.020 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.553969e-01 | 0.020 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.556300e-01 | 0.020 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.556300e-01 | 0.020 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.570684e-01 | 0.019 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.572920e-01 | 0.019 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.587014e-01 | 0.018 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.587014e-01 | 0.018 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.587014e-01 | 0.018 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.600897e-01 | 0.018 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.600897e-01 | 0.018 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.600897e-01 | 0.018 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.600897e-01 | 0.018 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.600897e-01 | 0.018 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.625880e-01 | 0.017 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.631392e-01 | 0.016 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.631392e-01 | 0.016 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.631392e-01 | 0.016 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.631392e-01 | 0.016 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.635515e-01 | 0.016 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.642891e-01 | 0.016 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.642891e-01 | 0.016 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.642891e-01 | 0.016 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.642891e-01 | 0.016 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.662749e-01 | 0.015 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.664200e-01 | 0.015 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.664200e-01 | 0.015 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.664200e-01 | 0.015 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.680468e-01 | 0.014 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.680468e-01 | 0.014 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.680468e-01 | 0.014 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.680468e-01 | 0.014 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.680468e-01 | 0.014 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.694188e-01 | 0.013 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.714093e-01 | 0.013 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.714093e-01 | 0.013 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.714285e-01 | 0.013 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.721585e-01 | 0.012 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.721585e-01 | 0.012 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.721585e-01 | 0.012 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.725205e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.744181e-01 | 0.011 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.744181e-01 | 0.011 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.744181e-01 | 0.011 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.744181e-01 | 0.011 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.746605e-01 | 0.011 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.746605e-01 | 0.011 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.747660e-01 | 0.011 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.749832e-01 | 0.011 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.749832e-01 | 0.011 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.753937e-01 | 0.011 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.770183e-01 | 0.010 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.771104e-01 | 0.010 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.771104e-01 | 0.010 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.771104e-01 | 0.010 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.771104e-01 | 0.010 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.771104e-01 | 0.010 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.771104e-01 | 0.010 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.788705e-01 | 0.009 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.790285e-01 | 0.009 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.790285e-01 | 0.009 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.795196e-01 | 0.009 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.795196e-01 | 0.009 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.795196e-01 | 0.009 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.797997e-01 | 0.009 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.798204e-01 | 0.009 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.806253e-01 | 0.008 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.809294e-01 | 0.008 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.809294e-01 | 0.008 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.811982e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.816753e-01 | 0.008 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.836042e-01 | 0.007 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.836208e-01 | 0.007 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.838041e-01 | 0.007 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.838392e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.842425e-01 | 0.007 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.845936e-01 | 0.007 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.857817e-01 | 0.006 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.858312e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.858312e-01 | 0.006 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.868265e-01 | 0.006 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.868745e-01 | 0.006 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.869930e-01 | 0.006 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.869930e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.880294e-01 | 0.005 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.882564e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.882564e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.882564e-01 | 0.005 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.892736e-01 | 0.005 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.894929e-01 | 0.005 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.894929e-01 | 0.005 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.894929e-01 | 0.005 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.894929e-01 | 0.005 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.894929e-01 | 0.005 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.897279e-01 | 0.004 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.903359e-01 | 0.004 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.905257e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.905992e-01 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.905992e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.911622e-01 | 0.004 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.911960e-01 | 0.004 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.914553e-01 | 0.004 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.914553e-01 | 0.004 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.915891e-01 | 0.004 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.915891e-01 | 0.004 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.919805e-01 | 0.003 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.924748e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.924748e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.924748e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.924748e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.925897e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.927244e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.931889e-01 | 0.003 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.932673e-01 | 0.003 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.932673e-01 | 0.003 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.939764e-01 | 0.003 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.940604e-01 | 0.003 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.942668e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.946108e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.950809e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.951247e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.951785e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.955414e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.955414e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.956445e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.956864e-01 | 0.002 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.959596e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.960469e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.960469e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.961408e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.961408e-01 | 0.002 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.961408e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.961408e-01 | 0.002 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.961408e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.962087e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.962162e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.963392e-01 | 0.002 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.965473e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.965999e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.969111e-01 | 0.001 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.969111e-01 | 0.001 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.972365e-01 | 0.001 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.973127e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.977882e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.979033e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.979807e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.979814e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.980213e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.980568e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.982816e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.983467e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.985041e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.985041e-01 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.985587e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.985833e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.986141e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.987258e-01 | 0.001 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.987678e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.988928e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.989838e-01 | 0.000 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.989858e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.989987e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.990042e-01 | 0.000 | 1 | 1 |
| Platelet homeostasis | R-HSA-418346 | 9.990536e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.991766e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.991883e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.992504e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.993222e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.993311e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.993791e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.994802e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.994802e-01 | 0.000 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.995324e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.995351e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.995351e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.995971e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.996280e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.996443e-01 | 0.000 | 1 | 1 |
| Innate Immune System | R-HSA-168249 | 9.996639e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.996672e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.997020e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997039e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997237e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.997337e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997381e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997618e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997618e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997618e-01 | 0.000 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.997869e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998295e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.998392e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.998475e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998475e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.998498e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998776e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998780e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998917e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.998934e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999132e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999302e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999363e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.999372e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999375e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.999500e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999500e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999579e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.999749e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999757e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999757e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999797e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999817e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999836e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999843e-01 | 0.000 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.999851e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.999851e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.999854e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.999869e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999872e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999874e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999894e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999896e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999912e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999913e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999916e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.999925e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999933e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999933e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999941e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999942e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999946e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999956e-01 | 0.000 | 1 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.999962e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999969e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999969e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999976e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999984e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999994e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999997e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999998e-01 | 0.000 | 1 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.110223e-14 | 13.955 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.137935e-14 | 13.089 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.759660e-14 | 13.058 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.939560e-13 | 12.712 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.209344e-13 | 12.656 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.599032e-13 | 12.585 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.845191e-12 | 11.734 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.764811e-11 | 10.753 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.894340e-11 | 10.723 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.246531e-10 | 9.904 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.797227e-10 | 9.319 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.428091e-10 | 9.265 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.297352e-09 | 8.201 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.422992e-08 | 7.847 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.115634e-08 | 7.386 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.665274e-08 | 7.331 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.376721e-08 | 7.195 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.091098e-08 | 7.215 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.220134e-07 | 6.914 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.035565e-07 | 6.691 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.688412e-07 | 6.571 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.405451e-07 | 6.130 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.995818e-07 | 6.097 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.302982e-06 | 5.885 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.256537e-06 | 5.647 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.564698e-06 | 5.591 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.739742e-06 | 5.562 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.524463e-06 | 5.453 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.043951e-06 | 5.297 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.413584e-06 | 5.267 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.005113e-06 | 5.155 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.611032e-06 | 5.119 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.679353e-06 | 5.062 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.574127e-06 | 5.067 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.679353e-06 | 5.062 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.796567e-06 | 5.056 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.189562e-05 | 4.925 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.326772e-05 | 4.877 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.467742e-05 | 4.833 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.539104e-05 | 4.813 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.633358e-05 | 4.787 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.732848e-05 | 4.761 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.735267e-05 | 4.761 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.007458e-05 | 4.697 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.375926e-05 | 4.624 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.375926e-05 | 4.624 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.831831e-05 | 4.548 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.781143e-05 | 4.556 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.978773e-05 | 4.526 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.132913e-05 | 4.504 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.345198e-05 | 4.476 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.586331e-05 | 4.445 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.535680e-05 | 4.343 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.126091e-05 | 4.213 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.195492e-05 | 4.208 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.492423e-05 | 4.188 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.113917e-05 | 4.148 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.093431e-05 | 4.092 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.516068e-05 | 4.070 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 9.097920e-05 | 4.041 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.690967e-05 | 4.014 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.047876e-04 | 3.980 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.047876e-04 | 3.980 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.105020e-04 | 3.957 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.312312e-04 | 3.882 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.384245e-04 | 3.859 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.451073e-04 | 3.838 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.668408e-04 | 3.778 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.665907e-04 | 3.778 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.610775e-04 | 3.793 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.675901e-04 | 3.776 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.675901e-04 | 3.776 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.650022e-04 | 3.783 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.587767e-04 | 3.799 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.781726e-04 | 3.749 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.006850e-04 | 3.697 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.938401e-04 | 3.713 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.006850e-04 | 3.697 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.039912e-04 | 3.690 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.052166e-04 | 3.688 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.416316e-04 | 3.617 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.353993e-04 | 3.628 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.397156e-04 | 3.620 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.502759e-04 | 3.602 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.510748e-04 | 3.600 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.603073e-04 | 3.585 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.053344e-04 | 3.515 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.987529e-04 | 3.525 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.041082e-04 | 3.517 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.222275e-04 | 3.492 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.252879e-04 | 3.488 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.311121e-04 | 3.480 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.404088e-04 | 3.468 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.439872e-04 | 3.463 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.770073e-04 | 3.424 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.770073e-04 | 3.424 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.854598e-04 | 3.414 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.977836e-04 | 3.400 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.055567e-04 | 3.392 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.062677e-04 | 3.391 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.753467e-04 | 3.323 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.525816e-04 | 3.344 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.497728e-04 | 3.260 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.192265e-04 | 3.208 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.192265e-04 | 3.208 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.800094e-04 | 3.237 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.800094e-04 | 3.237 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.773077e-04 | 3.239 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.866655e-04 | 3.232 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.835068e-04 | 3.165 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.970633e-04 | 3.157 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.049750e-04 | 3.152 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.425135e-04 | 3.129 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.255354e-04 | 3.083 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.873087e-04 | 3.104 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.731791e-04 | 3.112 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.160499e-04 | 3.088 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.255354e-04 | 3.083 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.471646e-04 | 3.024 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.523937e-04 | 3.021 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.523937e-04 | 3.021 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.610864e-04 | 3.017 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.015280e-03 | 2.993 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.046561e-03 | 2.980 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.049243e-03 | 2.979 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.040133e-03 | 2.983 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.067111e-03 | 2.972 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.051953e-03 | 2.978 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.012691e-03 | 2.995 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.081640e-03 | 2.966 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.087604e-03 | 2.964 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.098471e-03 | 2.959 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.110107e-03 | 2.955 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.110560e-03 | 2.954 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.140605e-03 | 2.943 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.159140e-03 | 2.936 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.239628e-03 | 2.907 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.326455e-03 | 2.877 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.350677e-03 | 2.869 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.379865e-03 | 2.860 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.493493e-03 | 2.826 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.527608e-03 | 2.816 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.527608e-03 | 2.816 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.956875e-03 | 2.708 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.899244e-03 | 2.721 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.032911e-03 | 2.692 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.021532e-03 | 2.694 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.090575e-03 | 2.680 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.095414e-03 | 2.679 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.152944e-03 | 2.667 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.252124e-03 | 2.647 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.330386e-03 | 2.633 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.343581e-03 | 2.630 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.503294e-03 | 2.601 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.726505e-03 | 2.564 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.938211e-03 | 2.532 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.938211e-03 | 2.532 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.945231e-03 | 2.531 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.952604e-03 | 2.530 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.988914e-03 | 2.524 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.072630e-03 | 2.512 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.287219e-03 | 2.483 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.764976e-03 | 2.424 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.373423e-03 | 2.472 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.868517e-03 | 2.412 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.902852e-03 | 2.409 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.002701e-03 | 2.398 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.165597e-03 | 2.380 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.256708e-03 | 2.371 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.284943e-03 | 2.368 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.343250e-03 | 2.362 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.553169e-03 | 2.342 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.553169e-03 | 2.342 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.309163e-03 | 2.275 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.309163e-03 | 2.275 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.309163e-03 | 2.275 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.309163e-03 | 2.275 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.250749e-03 | 2.280 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.185377e-03 | 2.285 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.996599e-03 | 2.301 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.900066e-03 | 2.310 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.487340e-03 | 2.261 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.487340e-03 | 2.261 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.487340e-03 | 2.261 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.825552e-03 | 2.235 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.826891e-03 | 2.235 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.140324e-03 | 2.212 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.621961e-03 | 2.179 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.731238e-03 | 2.172 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.742022e-03 | 2.171 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.762319e-03 | 2.170 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.762319e-03 | 2.170 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.880266e-03 | 2.162 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.887517e-03 | 2.162 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.421846e-03 | 2.129 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.778416e-03 | 2.109 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.959252e-03 | 2.099 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.112613e-03 | 2.091 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.237664e-03 | 2.084 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.237664e-03 | 2.084 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.237664e-03 | 2.084 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.732777e-03 | 2.012 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.732777e-03 | 2.012 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.589103e-03 | 2.018 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.939970e-03 | 2.049 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.920890e-03 | 2.003 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.003903e-02 | 1.998 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.318984e-03 | 2.031 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.005262e-02 | 1.998 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.013795e-02 | 1.994 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.013795e-02 | 1.994 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.031454e-02 | 1.987 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.048440e-02 | 1.979 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.048440e-02 | 1.979 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.048440e-02 | 1.979 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.049409e-02 | 1.979 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.084078e-02 | 1.965 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.101182e-02 | 1.958 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.125157e-02 | 1.949 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.156035e-02 | 1.937 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.233386e-02 | 1.909 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.254852e-02 | 1.901 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.255420e-02 | 1.901 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.312863e-02 | 1.882 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.330362e-02 | 1.876 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.350891e-02 | 1.869 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.372715e-02 | 1.862 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.389038e-02 | 1.857 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.397069e-02 | 1.855 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.515379e-02 | 1.819 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.579027e-02 | 1.802 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.579027e-02 | 1.802 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.713183e-02 | 1.766 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.906075e-02 | 1.720 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.906130e-02 | 1.720 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.906130e-02 | 1.720 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.882603e-02 | 1.725 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.879205e-02 | 1.726 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.601485e-02 | 1.795 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.711227e-02 | 1.767 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.717936e-02 | 1.765 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.604654e-02 | 1.795 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.604654e-02 | 1.795 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.879450e-02 | 1.726 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.836857e-02 | 1.736 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.740888e-02 | 1.759 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.655002e-02 | 1.781 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.604654e-02 | 1.795 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.926330e-02 | 1.715 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.942506e-02 | 1.712 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.945642e-02 | 1.711 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.999343e-02 | 1.699 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.041958e-02 | 1.690 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.041958e-02 | 1.690 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.092458e-02 | 1.679 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.103151e-02 | 1.677 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.103151e-02 | 1.677 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.103151e-02 | 1.677 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.103151e-02 | 1.677 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.120729e-02 | 1.674 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.126515e-02 | 1.672 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.126515e-02 | 1.672 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.126515e-02 | 1.672 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.186128e-02 | 1.660 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.285787e-02 | 1.641 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.285787e-02 | 1.641 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.301988e-02 | 1.638 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.301988e-02 | 1.638 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.301988e-02 | 1.638 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.315248e-02 | 1.635 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.345398e-02 | 1.630 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.489024e-02 | 1.604 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.489024e-02 | 1.604 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.594553e-02 | 1.586 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.594553e-02 | 1.586 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.594553e-02 | 1.586 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.704699e-02 | 1.568 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.704699e-02 | 1.568 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.741261e-02 | 1.562 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.741261e-02 | 1.562 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.741261e-02 | 1.562 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.741802e-02 | 1.562 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.302301e-02 | 1.481 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.302301e-02 | 1.481 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.131108e-02 | 1.504 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.131108e-02 | 1.504 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.414381e-02 | 1.467 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.414381e-02 | 1.467 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.890014e-02 | 1.539 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.283761e-02 | 1.484 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.302301e-02 | 1.481 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.027767e-02 | 1.519 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.451633e-02 | 1.462 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.820077e-02 | 1.550 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.401655e-02 | 1.468 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.162069e-02 | 1.500 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.382428e-02 | 1.471 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.478899e-02 | 1.459 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.518125e-02 | 1.454 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.570866e-02 | 1.447 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.639897e-02 | 1.439 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.667045e-02 | 1.436 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.730025e-02 | 1.428 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.732340e-02 | 1.428 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.732340e-02 | 1.428 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.732340e-02 | 1.428 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.732340e-02 | 1.428 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.865869e-02 | 1.413 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.917130e-02 | 1.407 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.961924e-02 | 1.402 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.992486e-02 | 1.399 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.065519e-02 | 1.391 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.093959e-02 | 1.388 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.203821e-02 | 1.376 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.236209e-02 | 1.373 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.259086e-02 | 1.371 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.259086e-02 | 1.371 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.399658e-02 | 1.357 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.418789e-02 | 1.355 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.418789e-02 | 1.355 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.446020e-02 | 1.352 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.538278e-02 | 1.343 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.538278e-02 | 1.343 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.541165e-02 | 1.343 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.619239e-02 | 1.335 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.619239e-02 | 1.335 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.755224e-02 | 1.323 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.755224e-02 | 1.323 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.755224e-02 | 1.323 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.697605e-02 | 1.244 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.163867e-02 | 1.287 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.163867e-02 | 1.287 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.163867e-02 | 1.287 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.163867e-02 | 1.287 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.133940e-02 | 1.290 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.935541e-02 | 1.227 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.542811e-02 | 1.256 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.808464e-02 | 1.318 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.649405e-02 | 1.248 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.935541e-02 | 1.227 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.004463e-02 | 1.222 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.165110e-02 | 1.210 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.451482e-02 | 1.263 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.479003e-02 | 1.261 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.273415e-02 | 1.278 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.163867e-02 | 1.287 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.697605e-02 | 1.244 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.275485e-02 | 1.278 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.133940e-02 | 1.290 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.615187e-02 | 1.251 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.451482e-02 | 1.263 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.797974e-02 | 1.319 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.797974e-02 | 1.319 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.932158e-02 | 1.307 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.275485e-02 | 1.278 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.697605e-02 | 1.244 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.479003e-02 | 1.261 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.672843e-02 | 1.246 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.163867e-02 | 1.287 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.163867e-02 | 1.287 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.542811e-02 | 1.256 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.932158e-02 | 1.307 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.163867e-02 | 1.287 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.163867e-02 | 1.287 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.163867e-02 | 1.287 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.089767e-02 | 1.215 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.165110e-02 | 1.210 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.165740e-02 | 1.210 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.288958e-02 | 1.201 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.288958e-02 | 1.201 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.288958e-02 | 1.201 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.319837e-02 | 1.199 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.485993e-02 | 1.188 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 8.275815e-02 | 1.082 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 8.275815e-02 | 1.082 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 8.275815e-02 | 1.082 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 8.275815e-02 | 1.082 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 8.275815e-02 | 1.082 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 8.275815e-02 | 1.082 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 8.275815e-02 | 1.082 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 8.275815e-02 | 1.082 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 8.275815e-02 | 1.082 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 8.275815e-02 | 1.082 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 8.275815e-02 | 1.082 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 8.275815e-02 | 1.082 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 8.275815e-02 | 1.082 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 8.275815e-02 | 1.082 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 8.275815e-02 | 1.082 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 8.275815e-02 | 1.082 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 8.275815e-02 | 1.082 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 8.275815e-02 | 1.082 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 9.577237e-02 | 1.019 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 8.708245e-02 | 1.060 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.448586e-02 | 1.073 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.724492e-02 | 1.012 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.724492e-02 | 1.012 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.739623e-02 | 1.111 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.740387e-02 | 1.058 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.740387e-02 | 1.058 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.740387e-02 | 1.058 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.940987e-02 | 1.159 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.940987e-02 | 1.159 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.940987e-02 | 1.159 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.940987e-02 | 1.159 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 9.805097e-02 | 1.009 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.748655e-02 | 1.111 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.748655e-02 | 1.111 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.748655e-02 | 1.111 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.748655e-02 | 1.111 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.607009e-02 | 1.065 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.607009e-02 | 1.065 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.607009e-02 | 1.065 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.515404e-02 | 1.022 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.281197e-02 | 1.082 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.030793e-02 | 1.095 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.670268e-02 | 1.062 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.670268e-02 | 1.062 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.514313e-02 | 1.124 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.005826e-02 | 1.155 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.281197e-02 | 1.082 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.515404e-02 | 1.022 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.515404e-02 | 1.022 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.805097e-02 | 1.009 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.068394e-02 | 1.042 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.282507e-02 | 1.032 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.670268e-02 | 1.062 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.448586e-02 | 1.073 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.090584e-02 | 1.149 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.260940e-02 | 1.139 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.805097e-02 | 1.009 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.534901e-02 | 1.123 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.829730e-02 | 1.166 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.460309e-02 | 1.127 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.176553e-02 | 1.037 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.068394e-02 | 1.042 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.177536e-02 | 1.144 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.534901e-02 | 1.123 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 9.068394e-02 | 1.042 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.481008e-02 | 1.023 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.740387e-02 | 1.058 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.260940e-02 | 1.139 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.940987e-02 | 1.159 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.829730e-02 | 1.166 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.804313e-02 | 1.167 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 7.028138e-02 | 1.153 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 9.577237e-02 | 1.019 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.708245e-02 | 1.060 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.740387e-02 | 1.058 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.805097e-02 | 1.009 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.739623e-02 | 1.111 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.523054e-02 | 1.021 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.212695e-02 | 1.142 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.802474e-02 | 1.009 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.281197e-02 | 1.082 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.804313e-02 | 1.167 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.804313e-02 | 1.167 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.281197e-02 | 1.082 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.448586e-02 | 1.073 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.805097e-02 | 1.009 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.708245e-02 | 1.060 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.448586e-02 | 1.073 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.448586e-02 | 1.073 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.739623e-02 | 1.111 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.605966e-02 | 1.119 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.868302e-02 | 1.104 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.534901e-02 | 1.123 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.829730e-02 | 1.166 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.045544e-02 | 1.094 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.260940e-02 | 1.139 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.985922e-02 | 1.156 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.463937e-02 | 1.127 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.740387e-02 | 1.058 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.448586e-02 | 1.073 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.740387e-02 | 1.058 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.162801e-02 | 1.038 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.364217e-02 | 1.133 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.724492e-02 | 1.012 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.896101e-02 | 1.005 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.003739e-01 | 0.998 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.004076e-01 | 0.998 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.004076e-01 | 0.998 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.004076e-01 | 0.998 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.004076e-01 | 0.998 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.037830e-01 | 0.984 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.041776e-01 | 0.982 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.041776e-01 | 0.982 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.041776e-01 | 0.982 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.044296e-01 | 0.981 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.047294e-01 | 0.980 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.047294e-01 | 0.980 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.047294e-01 | 0.980 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.047294e-01 | 0.980 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.054727e-01 | 0.977 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.054859e-01 | 0.977 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.075234e-01 | 0.968 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.076376e-01 | 0.968 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.076376e-01 | 0.968 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.076376e-01 | 0.968 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.076469e-01 | 0.968 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.076469e-01 | 0.968 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.076469e-01 | 0.968 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.081013e-01 | 0.966 | 1 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.083268e-01 | 0.965 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.093186e-01 | 0.961 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.093186e-01 | 0.961 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.093186e-01 | 0.961 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.093186e-01 | 0.961 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.102128e-01 | 0.958 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.104431e-01 | 0.957 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.108443e-01 | 0.955 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.109450e-01 | 0.955 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.147850e-01 | 0.940 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.147850e-01 | 0.940 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.152079e-01 | 0.939 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.167068e-01 | 0.933 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.167068e-01 | 0.933 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.167068e-01 | 0.933 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.167068e-01 | 0.933 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.167068e-01 | 0.933 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.171218e-01 | 0.931 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.171218e-01 | 0.931 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.179766e-01 | 0.928 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.204784e-01 | 0.919 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.224696e-01 | 0.912 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.234131e-01 | 0.909 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.234131e-01 | 0.909 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.234131e-01 | 0.909 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.234131e-01 | 0.909 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.234131e-01 | 0.909 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.234131e-01 | 0.909 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.240152e-01 | 0.907 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.251563e-01 | 0.903 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.251563e-01 | 0.903 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.252361e-01 | 0.902 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.252361e-01 | 0.902 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.253073e-01 | 0.902 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.253073e-01 | 0.902 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.253073e-01 | 0.902 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.256702e-01 | 0.901 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.261598e-01 | 0.899 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.261598e-01 | 0.899 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.261598e-01 | 0.899 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.277552e-01 | 0.894 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.299759e-01 | 0.886 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.336221e-01 | 0.874 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.336221e-01 | 0.874 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.359868e-01 | 0.867 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.359868e-01 | 0.867 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.359868e-01 | 0.867 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.359868e-01 | 0.867 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.362808e-01 | 0.866 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.362808e-01 | 0.866 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.367923e-01 | 0.864 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.395777e-01 | 0.855 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.395777e-01 | 0.855 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.395777e-01 | 0.855 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.395777e-01 | 0.855 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.395777e-01 | 0.855 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.403678e-01 | 0.853 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.403678e-01 | 0.853 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.403678e-01 | 0.853 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.586719e-01 | 0.799 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.586719e-01 | 0.799 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.586719e-01 | 0.799 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.586719e-01 | 0.799 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.586719e-01 | 0.799 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.586719e-01 | 0.799 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.586719e-01 | 0.799 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.586719e-01 | 0.799 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.586719e-01 | 0.799 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 1.586719e-01 | 0.799 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.586719e-01 | 0.799 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.283069e-01 | 0.641 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.283069e-01 | 0.641 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.283069e-01 | 0.641 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.283069e-01 | 0.641 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 2.283069e-01 | 0.641 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.283069e-01 | 0.641 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.526738e-01 | 0.816 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.830975e-01 | 0.737 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.418279e-01 | 0.848 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.142916e-01 | 0.669 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 2.142916e-01 | 0.669 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.142916e-01 | 0.669 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.142916e-01 | 0.669 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.621202e-01 | 0.790 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.621202e-01 | 0.790 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.459206e-01 | 0.609 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.459206e-01 | 0.609 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.459206e-01 | 0.609 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.459206e-01 | 0.609 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.832148e-01 | 0.737 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.832148e-01 | 0.737 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.561832e-01 | 0.806 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.776991e-01 | 0.556 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.776991e-01 | 0.556 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.726237e-01 | 0.763 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.726237e-01 | 0.763 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.726237e-01 | 0.763 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.726237e-01 | 0.763 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.595106e-01 | 0.797 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.250841e-01 | 0.648 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.731008e-01 | 0.564 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.731008e-01 | 0.564 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.527785e-01 | 0.816 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.620549e-01 | 0.582 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.625867e-01 | 0.789 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.809565e-01 | 0.551 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.240864e-01 | 0.650 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.520198e-01 | 0.599 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.520198e-01 | 0.599 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.520198e-01 | 0.599 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.953550e-01 | 0.709 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.390361e-01 | 0.622 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.663356e-01 | 0.575 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.808493e-01 | 0.552 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.032172e-01 | 0.692 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.228973e-01 | 0.652 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.614307e-01 | 0.583 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.710634e-01 | 0.567 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.476882e-01 | 0.831 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.379281e-01 | 0.624 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.033264e-01 | 0.692 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.823284e-01 | 0.549 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.884953e-01 | 0.725 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.499092e-01 | 0.602 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.418279e-01 | 0.848 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.272984e-01 | 0.643 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.919297e-01 | 0.717 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.731008e-01 | 0.564 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 2.185308e-01 | 0.660 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.499092e-01 | 0.602 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.479170e-01 | 0.606 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.479170e-01 | 0.606 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.118152e-01 | 0.674 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.919297e-01 | 0.717 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.466039e-01 | 0.834 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.823284e-01 | 0.549 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.660076e-01 | 0.575 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 1.526738e-01 | 0.816 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.499092e-01 | 0.602 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.518120e-01 | 0.599 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.868797e-01 | 0.728 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.323132e-01 | 0.634 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.105205e-01 | 0.677 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.157958e-01 | 0.666 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.586719e-01 | 0.799 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.832148e-01 | 0.737 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 2.776991e-01 | 0.556 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.595106e-01 | 0.797 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.595106e-01 | 0.797 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.731008e-01 | 0.564 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.499092e-01 | 0.602 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.520198e-01 | 0.599 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.150281e-01 | 0.668 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.884953e-01 | 0.725 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.240864e-01 | 0.650 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.240864e-01 | 0.650 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.476882e-01 | 0.831 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.526738e-01 | 0.816 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.660076e-01 | 0.575 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.459206e-01 | 0.609 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.663864e-01 | 0.574 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.663594e-01 | 0.779 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.561832e-01 | 0.806 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.567163e-01 | 0.805 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.698907e-01 | 0.770 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.776991e-01 | 0.556 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.776991e-01 | 0.556 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.561832e-01 | 0.806 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.726237e-01 | 0.763 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.321814e-01 | 0.634 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.586719e-01 | 0.799 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.283069e-01 | 0.641 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.832148e-01 | 0.737 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 2.500423e-01 | 0.602 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.717273e-01 | 0.765 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.843167e-01 | 0.734 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.843167e-01 | 0.734 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.787908e-01 | 0.748 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.726790e-01 | 0.763 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.571753e-01 | 0.804 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.141563e-01 | 0.669 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.823284e-01 | 0.549 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.502694e-01 | 0.602 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.015232e-01 | 0.696 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.461765e-01 | 0.835 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.310823e-01 | 0.636 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.500423e-01 | 0.602 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.630113e-01 | 0.788 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.379281e-01 | 0.624 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.865012e-01 | 0.729 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.936706e-01 | 0.713 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.776991e-01 | 0.556 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.621857e-01 | 0.581 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.066185e-01 | 0.685 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.502694e-01 | 0.602 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.526738e-01 | 0.816 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.776991e-01 | 0.556 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.476882e-01 | 0.831 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.432645e-01 | 0.844 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.902952e-01 | 0.721 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.518120e-01 | 0.599 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.015232e-01 | 0.696 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.466039e-01 | 0.834 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.620549e-01 | 0.582 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.787908e-01 | 0.748 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.152179e-01 | 0.667 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.415715e-01 | 0.617 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.936706e-01 | 0.713 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.520198e-01 | 0.599 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.240250e-01 | 0.650 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.283069e-01 | 0.641 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.830975e-01 | 0.737 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.561832e-01 | 0.806 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.726237e-01 | 0.763 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.272984e-01 | 0.643 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.418792e-01 | 0.616 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.499092e-01 | 0.602 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.116286e-01 | 0.674 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.972557e-01 | 0.705 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.459206e-01 | 0.609 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.434226e-01 | 0.843 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.776991e-01 | 0.556 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.600989e-01 | 0.796 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.499092e-01 | 0.602 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.823284e-01 | 0.549 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.787908e-01 | 0.748 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.787908e-01 | 0.748 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.600324e-01 | 0.796 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.294623e-01 | 0.639 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.814063e-01 | 0.551 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.526738e-01 | 0.816 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.142916e-01 | 0.669 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.600989e-01 | 0.796 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.071361e-01 | 0.684 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.185308e-01 | 0.660 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.379281e-01 | 0.624 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.647867e-01 | 0.577 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.248701e-01 | 0.648 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.600989e-01 | 0.796 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.379281e-01 | 0.624 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.830975e-01 | 0.737 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.142916e-01 | 0.669 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.776991e-01 | 0.556 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.272984e-01 | 0.643 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.896286e-01 | 0.722 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.675927e-01 | 0.776 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.775397e-01 | 0.751 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.278747e-01 | 0.642 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.790547e-01 | 0.747 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.459206e-01 | 0.609 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.561832e-01 | 0.806 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.808493e-01 | 0.552 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.476700e-01 | 0.606 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.071361e-01 | 0.684 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.499092e-01 | 0.602 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.009514e-01 | 0.697 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.864978e-01 | 0.543 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.921822e-01 | 0.534 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.921822e-01 | 0.534 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.921822e-01 | 0.534 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.921822e-01 | 0.534 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.955347e-01 | 0.529 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.955347e-01 | 0.529 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.963668e-01 | 0.528 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.963668e-01 | 0.528 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.979412e-01 | 0.526 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.994645e-01 | 0.524 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.000575e-01 | 0.523 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.000575e-01 | 0.523 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.000575e-01 | 0.523 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.000575e-01 | 0.523 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.045861e-01 | 0.516 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.093859e-01 | 0.509 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.093859e-01 | 0.509 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.093859e-01 | 0.509 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.093859e-01 | 0.509 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.103657e-01 | 0.508 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.103657e-01 | 0.508 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.103657e-01 | 0.508 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.103657e-01 | 0.508 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.103657e-01 | 0.508 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.103657e-01 | 0.508 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.150381e-01 | 0.502 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.154399e-01 | 0.501 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.193015e-01 | 0.496 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.193015e-01 | 0.496 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.197408e-01 | 0.495 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.197408e-01 | 0.495 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.197408e-01 | 0.495 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.197408e-01 | 0.495 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.197408e-01 | 0.495 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.239382e-01 | 0.490 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.253167e-01 | 0.488 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.253167e-01 | 0.488 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.322553e-01 | 0.479 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.366167e-01 | 0.473 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.386345e-01 | 0.470 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.407787e-01 | 0.468 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.407787e-01 | 0.468 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 3.407787e-01 | 0.468 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.407787e-01 | 0.468 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.431303e-01 | 0.465 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.440245e-01 | 0.463 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.440245e-01 | 0.463 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.440245e-01 | 0.463 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.440245e-01 | 0.463 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.490995e-01 | 0.457 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.490995e-01 | 0.457 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.490995e-01 | 0.457 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.507739e-01 | 0.455 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 3.507739e-01 | 0.455 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.507739e-01 | 0.455 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.507739e-01 | 0.455 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 3.507739e-01 | 0.455 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.507739e-01 | 0.455 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.507739e-01 | 0.455 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.507739e-01 | 0.455 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.557504e-01 | 0.449 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.580049e-01 | 0.446 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.580049e-01 | 0.446 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.580049e-01 | 0.446 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.580049e-01 | 0.446 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.580049e-01 | 0.446 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.580049e-01 | 0.446 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.621806e-01 | 0.441 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.648846e-01 | 0.438 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.654279e-01 | 0.437 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.654279e-01 | 0.437 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.656169e-01 | 0.437 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.656169e-01 | 0.437 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.659873e-01 | 0.437 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.664505e-01 | 0.436 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.664505e-01 | 0.436 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.664505e-01 | 0.436 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.717091e-01 | 0.430 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.717091e-01 | 0.430 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.717091e-01 | 0.430 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.717091e-01 | 0.430 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.773637e-01 | 0.423 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.773637e-01 | 0.423 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.828860e-01 | 0.417 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.828860e-01 | 0.417 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.852195e-01 | 0.414 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.860091e-01 | 0.413 | 0 | 0 |
| Translation | R-HSA-72766 | 3.864337e-01 | 0.413 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.873097e-01 | 0.412 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.879215e-01 | 0.411 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.896242e-01 | 0.409 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.896242e-01 | 0.409 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.966649e-01 | 0.402 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.966649e-01 | 0.402 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.994907e-01 | 0.398 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.997642e-01 | 0.398 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.020387e-01 | 0.396 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.020387e-01 | 0.396 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.045186e-01 | 0.393 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.045186e-01 | 0.393 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.045186e-01 | 0.393 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.045186e-01 | 0.393 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.045186e-01 | 0.393 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.045186e-01 | 0.393 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.045186e-01 | 0.393 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.045186e-01 | 0.393 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.045186e-01 | 0.393 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 4.125812e-01 | 0.384 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.158653e-01 | 0.381 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.158653e-01 | 0.381 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.161542e-01 | 0.381 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.165921e-01 | 0.380 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.165921e-01 | 0.380 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.172478e-01 | 0.380 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.242262e-01 | 0.372 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.275427e-01 | 0.369 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.289802e-01 | 0.368 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.316552e-01 | 0.365 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.316552e-01 | 0.365 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.318252e-01 | 0.365 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.319726e-01 | 0.365 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.330062e-01 | 0.364 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.333412e-01 | 0.363 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.349245e-01 | 0.362 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.352588e-01 | 0.361 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.352588e-01 | 0.361 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.362998e-01 | 0.360 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.519986e-01 | 0.345 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.528222e-01 | 0.344 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.538171e-01 | 0.343 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 4.538171e-01 | 0.343 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.538171e-01 | 0.343 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.538171e-01 | 0.343 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.538171e-01 | 0.343 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.538171e-01 | 0.343 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.538171e-01 | 0.343 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.538171e-01 | 0.343 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.538171e-01 | 0.343 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 4.538171e-01 | 0.343 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.538171e-01 | 0.343 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.560243e-01 | 0.341 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.576011e-01 | 0.340 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.576011e-01 | 0.340 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.576011e-01 | 0.340 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.604689e-01 | 0.337 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.604689e-01 | 0.337 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.604689e-01 | 0.337 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.604689e-01 | 0.337 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.612690e-01 | 0.336 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.627916e-01 | 0.335 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.627916e-01 | 0.335 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 4.650773e-01 | 0.332 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.664968e-01 | 0.331 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.664968e-01 | 0.331 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.705683e-01 | 0.327 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.724730e-01 | 0.326 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.724730e-01 | 0.326 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.724730e-01 | 0.326 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.735521e-01 | 0.325 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.761244e-01 | 0.322 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.761244e-01 | 0.322 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.791100e-01 | 0.320 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.791100e-01 | 0.320 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.795587e-01 | 0.319 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.795587e-01 | 0.319 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.795587e-01 | 0.319 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.795587e-01 | 0.319 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.795587e-01 | 0.319 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.884096e-01 | 0.311 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 4.884096e-01 | 0.311 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.884096e-01 | 0.311 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.908965e-01 | 0.309 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.908965e-01 | 0.309 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.939530e-01 | 0.306 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.990347e-01 | 0.302 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.990347e-01 | 0.302 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.990370e-01 | 0.302 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 4.990370e-01 | 0.302 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.990370e-01 | 0.302 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.990370e-01 | 0.302 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.990370e-01 | 0.302 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.990370e-01 | 0.302 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.990370e-01 | 0.302 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.990370e-01 | 0.302 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.990370e-01 | 0.302 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.990370e-01 | 0.302 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.990370e-01 | 0.302 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.990370e-01 | 0.302 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.010753e-01 | 0.300 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.010886e-01 | 0.300 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.010886e-01 | 0.300 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.054536e-01 | 0.296 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.054536e-01 | 0.296 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.096559e-01 | 0.293 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.096559e-01 | 0.293 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.108052e-01 | 0.292 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.108052e-01 | 0.292 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.134177e-01 | 0.290 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.150177e-01 | 0.288 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.154246e-01 | 0.288 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.154246e-01 | 0.288 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.154246e-01 | 0.288 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.154246e-01 | 0.288 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.154246e-01 | 0.288 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 5.154246e-01 | 0.288 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.154309e-01 | 0.288 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.161262e-01 | 0.287 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.198951e-01 | 0.284 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.221535e-01 | 0.282 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.221535e-01 | 0.282 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.232314e-01 | 0.281 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.240784e-01 | 0.281 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.307842e-01 | 0.275 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.370379e-01 | 0.270 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.405155e-01 | 0.267 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.405155e-01 | 0.267 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.405155e-01 | 0.267 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.405155e-01 | 0.267 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.405155e-01 | 0.267 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.405155e-01 | 0.267 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.405155e-01 | 0.267 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.405155e-01 | 0.267 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.405155e-01 | 0.267 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.405155e-01 | 0.267 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.414756e-01 | 0.266 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.414756e-01 | 0.266 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.414756e-01 | 0.266 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.427219e-01 | 0.265 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.482590e-01 | 0.261 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.521177e-01 | 0.258 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.552125e-01 | 0.256 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.610991e-01 | 0.251 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.616184e-01 | 0.251 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.616184e-01 | 0.251 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.621553e-01 | 0.250 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.627674e-01 | 0.250 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.630292e-01 | 0.249 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.640907e-01 | 0.249 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.665371e-01 | 0.247 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.665371e-01 | 0.247 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.665371e-01 | 0.247 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.665371e-01 | 0.247 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.677869e-01 | 0.246 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.770770e-01 | 0.239 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.778655e-01 | 0.238 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.785620e-01 | 0.238 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.785620e-01 | 0.238 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.785620e-01 | 0.238 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.785620e-01 | 0.238 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.785620e-01 | 0.238 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.785620e-01 | 0.238 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.785620e-01 | 0.238 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.785620e-01 | 0.238 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.785620e-01 | 0.238 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.785620e-01 | 0.238 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.785620e-01 | 0.238 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.804136e-01 | 0.236 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.913626e-01 | 0.228 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.913626e-01 | 0.228 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.069243e-01 | 0.217 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.109658e-01 | 0.214 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.120646e-01 | 0.213 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.134601e-01 | 0.212 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.134601e-01 | 0.212 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.134601e-01 | 0.212 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.134601e-01 | 0.212 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.134601e-01 | 0.212 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.134601e-01 | 0.212 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.134601e-01 | 0.212 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.134601e-01 | 0.212 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.134601e-01 | 0.212 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.134601e-01 | 0.212 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.134601e-01 | 0.212 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.134601e-01 | 0.212 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.136415e-01 | 0.212 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.136415e-01 | 0.212 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.136415e-01 | 0.212 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.136415e-01 | 0.212 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.253861e-01 | 0.204 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.300911e-01 | 0.201 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.356813e-01 | 0.197 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.356813e-01 | 0.197 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.360021e-01 | 0.197 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.361763e-01 | 0.196 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.361763e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.361763e-01 | 0.196 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.373521e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.418897e-01 | 0.193 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.442932e-01 | 0.191 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.454704e-01 | 0.190 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.454704e-01 | 0.190 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.454704e-01 | 0.190 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.454704e-01 | 0.190 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.454704e-01 | 0.190 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.454704e-01 | 0.190 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.454704e-01 | 0.190 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.454704e-01 | 0.190 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.454704e-01 | 0.190 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.454704e-01 | 0.190 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.499176e-01 | 0.187 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.545420e-01 | 0.184 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.545420e-01 | 0.184 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.545420e-01 | 0.184 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.567224e-01 | 0.183 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.567224e-01 | 0.183 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.567224e-01 | 0.183 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.567224e-01 | 0.183 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.604753e-01 | 0.180 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.651324e-01 | 0.177 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.711389e-01 | 0.173 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.711553e-01 | 0.173 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.748316e-01 | 0.171 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.748316e-01 | 0.171 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.748316e-01 | 0.171 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.748316e-01 | 0.171 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.748316e-01 | 0.171 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.748316e-01 | 0.171 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.748316e-01 | 0.171 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.748316e-01 | 0.171 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.748316e-01 | 0.171 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.748316e-01 | 0.171 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 6.748316e-01 | 0.171 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.748316e-01 | 0.171 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.752361e-01 | 0.171 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.767789e-01 | 0.170 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.767789e-01 | 0.170 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.860357e-01 | 0.164 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.860357e-01 | 0.164 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.871425e-01 | 0.163 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.871425e-01 | 0.163 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.871425e-01 | 0.163 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.871425e-01 | 0.163 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.958697e-01 | 0.157 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.958697e-01 | 0.157 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.958697e-01 | 0.157 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.963427e-01 | 0.157 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.982682e-01 | 0.156 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.987283e-01 | 0.156 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.017627e-01 | 0.154 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.017627e-01 | 0.154 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.017627e-01 | 0.154 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.017627e-01 | 0.154 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.017627e-01 | 0.154 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.017627e-01 | 0.154 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.017627e-01 | 0.154 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.017627e-01 | 0.154 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.017627e-01 | 0.154 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.017627e-01 | 0.154 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.017627e-01 | 0.154 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.017627e-01 | 0.154 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 7.025551e-01 | 0.153 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.045915e-01 | 0.152 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.067138e-01 | 0.151 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.111136e-01 | 0.148 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.118761e-01 | 0.148 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.118761e-01 | 0.148 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.140170e-01 | 0.146 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.173812e-01 | 0.144 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.218201e-01 | 0.142 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.226276e-01 | 0.141 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.258087e-01 | 0.139 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.264649e-01 | 0.139 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.264649e-01 | 0.139 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.264649e-01 | 0.139 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.264649e-01 | 0.139 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.264649e-01 | 0.139 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.264649e-01 | 0.139 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.312462e-01 | 0.136 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.312462e-01 | 0.136 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.329646e-01 | 0.135 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.415880e-01 | 0.130 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.423729e-01 | 0.129 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.475849e-01 | 0.126 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.475849e-01 | 0.126 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.475849e-01 | 0.126 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.491223e-01 | 0.125 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.491223e-01 | 0.125 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.491223e-01 | 0.125 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.491223e-01 | 0.125 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.491223e-01 | 0.125 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.491223e-01 | 0.125 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.491223e-01 | 0.125 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.491223e-01 | 0.125 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.491223e-01 | 0.125 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.491223e-01 | 0.125 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.491223e-01 | 0.125 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.584137e-01 | 0.120 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.602443e-01 | 0.119 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.630622e-01 | 0.117 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.630622e-01 | 0.117 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.630622e-01 | 0.117 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.699043e-01 | 0.114 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.699043e-01 | 0.114 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.699043e-01 | 0.114 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.699043e-01 | 0.114 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.699043e-01 | 0.114 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.699043e-01 | 0.114 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.709745e-01 | 0.113 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.709745e-01 | 0.113 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.710887e-01 | 0.113 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.722687e-01 | 0.112 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.737369e-01 | 0.111 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.740724e-01 | 0.111 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.746720e-01 | 0.111 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.763131e-01 | 0.110 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.777088e-01 | 0.109 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.777088e-01 | 0.109 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.777088e-01 | 0.109 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.777088e-01 | 0.109 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.792431e-01 | 0.108 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.812675e-01 | 0.107 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.819489e-01 | 0.107 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.889658e-01 | 0.103 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.889658e-01 | 0.103 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.889658e-01 | 0.103 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.889658e-01 | 0.103 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.889658e-01 | 0.103 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.889658e-01 | 0.103 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.889658e-01 | 0.103 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.889658e-01 | 0.103 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.889658e-01 | 0.103 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.914765e-01 | 0.102 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.915560e-01 | 0.102 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.915560e-01 | 0.102 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.915560e-01 | 0.102 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.915560e-01 | 0.102 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.944908e-01 | 0.100 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.944908e-01 | 0.100 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.959665e-01 | 0.099 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.964501e-01 | 0.099 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.964501e-01 | 0.099 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.004187e-01 | 0.097 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.010337e-01 | 0.096 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.020626e-01 | 0.096 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.046358e-01 | 0.094 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.054730e-01 | 0.094 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.064493e-01 | 0.093 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.064493e-01 | 0.093 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.064493e-01 | 0.093 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.064493e-01 | 0.093 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.064493e-01 | 0.093 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.064493e-01 | 0.093 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.064493e-01 | 0.093 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.064493e-01 | 0.093 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.064493e-01 | 0.093 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.064493e-01 | 0.093 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.071173e-01 | 0.093 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.169802e-01 | 0.088 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.169802e-01 | 0.088 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.169802e-01 | 0.088 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.169802e-01 | 0.088 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.169802e-01 | 0.088 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.193736e-01 | 0.087 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.224854e-01 | 0.085 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.224854e-01 | 0.085 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.224854e-01 | 0.085 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.224854e-01 | 0.085 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.224854e-01 | 0.085 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.224854e-01 | 0.085 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.224854e-01 | 0.085 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.224854e-01 | 0.085 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.224854e-01 | 0.085 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.224927e-01 | 0.085 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.245239e-01 | 0.084 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.259564e-01 | 0.083 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.259564e-01 | 0.083 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.259564e-01 | 0.083 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.267205e-01 | 0.083 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.274147e-01 | 0.082 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.286212e-01 | 0.082 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.286212e-01 | 0.082 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.286212e-01 | 0.082 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.291212e-01 | 0.081 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.293834e-01 | 0.081 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.293834e-01 | 0.081 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.294115e-01 | 0.081 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.343164e-01 | 0.079 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.354875e-01 | 0.078 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.354875e-01 | 0.078 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.371936e-01 | 0.077 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.371936e-01 | 0.077 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.371936e-01 | 0.077 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.371936e-01 | 0.077 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.371936e-01 | 0.077 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.371936e-01 | 0.077 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.371936e-01 | 0.077 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.371936e-01 | 0.077 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.371936e-01 | 0.077 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.395906e-01 | 0.076 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.418763e-01 | 0.075 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.426240e-01 | 0.074 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.457978e-01 | 0.073 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.491844e-01 | 0.071 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.499198e-01 | 0.071 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.506840e-01 | 0.070 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.506840e-01 | 0.070 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.506840e-01 | 0.070 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.506840e-01 | 0.070 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.506840e-01 | 0.070 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.506840e-01 | 0.070 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.532050e-01 | 0.069 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.534929e-01 | 0.069 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.534929e-01 | 0.069 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.534929e-01 | 0.069 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.534929e-01 | 0.069 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.550611e-01 | 0.068 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.567114e-01 | 0.067 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.596395e-01 | 0.066 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.596395e-01 | 0.066 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.596395e-01 | 0.066 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.600265e-01 | 0.065 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.614224e-01 | 0.065 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.630573e-01 | 0.064 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.630573e-01 | 0.064 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.630573e-01 | 0.064 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.630573e-01 | 0.064 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.630573e-01 | 0.064 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.630573e-01 | 0.064 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.633509e-01 | 0.064 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.633509e-01 | 0.064 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.679068e-01 | 0.062 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.679739e-01 | 0.061 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.687798e-01 | 0.061 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.687798e-01 | 0.061 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.692329e-01 | 0.061 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.694117e-01 | 0.061 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.694117e-01 | 0.061 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.694117e-01 | 0.061 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.697299e-01 | 0.061 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.744060e-01 | 0.058 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.744060e-01 | 0.058 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.744060e-01 | 0.058 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.744060e-01 | 0.058 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.744060e-01 | 0.058 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.744060e-01 | 0.058 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.744060e-01 | 0.058 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.746453e-01 | 0.058 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.766521e-01 | 0.057 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.773698e-01 | 0.057 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.773698e-01 | 0.057 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.773698e-01 | 0.057 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.817342e-01 | 0.055 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.836952e-01 | 0.054 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.848147e-01 | 0.053 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.848147e-01 | 0.053 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.848147e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.848147e-01 | 0.053 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.848147e-01 | 0.053 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.848147e-01 | 0.053 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.854381e-01 | 0.053 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.854381e-01 | 0.053 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.854381e-01 | 0.053 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.854381e-01 | 0.053 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.854381e-01 | 0.053 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.854381e-01 | 0.053 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.867138e-01 | 0.052 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.872342e-01 | 0.052 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.930120e-01 | 0.049 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.943615e-01 | 0.048 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.943615e-01 | 0.048 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.943615e-01 | 0.048 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.943615e-01 | 0.048 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.943615e-01 | 0.048 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.958547e-01 | 0.048 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.967134e-01 | 0.047 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.001181e-01 | 0.046 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.001181e-01 | 0.046 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.031174e-01 | 0.044 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.031174e-01 | 0.044 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.067818e-01 | 0.042 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.104148e-01 | 0.041 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.111482e-01 | 0.040 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.111482e-01 | 0.040 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.130277e-01 | 0.040 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.154281e-01 | 0.038 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.154281e-01 | 0.038 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.154281e-01 | 0.038 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.177826e-01 | 0.037 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.185136e-01 | 0.037 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.185136e-01 | 0.037 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.185136e-01 | 0.037 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.185136e-01 | 0.037 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.188791e-01 | 0.037 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.188844e-01 | 0.037 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.237027e-01 | 0.034 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.243586e-01 | 0.034 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.252689e-01 | 0.034 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.252689e-01 | 0.034 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.252689e-01 | 0.034 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.252689e-01 | 0.034 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.252689e-01 | 0.034 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.256986e-01 | 0.034 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.282575e-01 | 0.032 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.284983e-01 | 0.032 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.294875e-01 | 0.032 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.314646e-01 | 0.031 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.314646e-01 | 0.031 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.314646e-01 | 0.031 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.314646e-01 | 0.031 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.319299e-01 | 0.031 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.321226e-01 | 0.031 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.343536e-01 | 0.029 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.343536e-01 | 0.029 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.343536e-01 | 0.029 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.366258e-01 | 0.028 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.371469e-01 | 0.028 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.371469e-01 | 0.028 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.371469e-01 | 0.028 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.371469e-01 | 0.028 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.371469e-01 | 0.028 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.371469e-01 | 0.028 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.387746e-01 | 0.027 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.387746e-01 | 0.027 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.388823e-01 | 0.027 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.423585e-01 | 0.026 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.423585e-01 | 0.026 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.423585e-01 | 0.026 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.429707e-01 | 0.026 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.461754e-01 | 0.024 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.468923e-01 | 0.024 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.468923e-01 | 0.024 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.468923e-01 | 0.024 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.471381e-01 | 0.024 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.471381e-01 | 0.024 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.471381e-01 | 0.024 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.474997e-01 | 0.023 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.491326e-01 | 0.023 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.495067e-01 | 0.023 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.515218e-01 | 0.022 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.515218e-01 | 0.022 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.515218e-01 | 0.022 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.532087e-01 | 0.021 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.537556e-01 | 0.021 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.539775e-01 | 0.020 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.547843e-01 | 0.020 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.555421e-01 | 0.020 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.555421e-01 | 0.020 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.580281e-01 | 0.019 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.582492e-01 | 0.019 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.601532e-01 | 0.018 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.616024e-01 | 0.017 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.629349e-01 | 0.016 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.663304e-01 | 0.015 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.664775e-01 | 0.015 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.670154e-01 | 0.015 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.678407e-01 | 0.014 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.685563e-01 | 0.014 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.685563e-01 | 0.014 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.688848e-01 | 0.014 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.694647e-01 | 0.013 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.701322e-01 | 0.013 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.705755e-01 | 0.013 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.711647e-01 | 0.013 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.711647e-01 | 0.013 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.711647e-01 | 0.013 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.740737e-01 | 0.011 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.742646e-01 | 0.011 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.743574e-01 | 0.011 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.753258e-01 | 0.011 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.753258e-01 | 0.011 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.757507e-01 | 0.011 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.757507e-01 | 0.011 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.760647e-01 | 0.011 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.760889e-01 | 0.011 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.777627e-01 | 0.010 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.777627e-01 | 0.010 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.788196e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.788196e-01 | 0.009 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.793694e-01 | 0.009 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.796079e-01 | 0.009 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.808417e-01 | 0.008 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.808417e-01 | 0.008 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.808417e-01 | 0.008 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.822118e-01 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.828518e-01 | 0.008 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.828518e-01 | 0.008 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.828518e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 9.834866e-01 | 0.007 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.834866e-01 | 0.007 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.835993e-01 | 0.007 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.838298e-01 | 0.007 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.842749e-01 | 0.007 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.842749e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.855800e-01 | 0.006 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.865033e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.865033e-01 | 0.006 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.867769e-01 | 0.006 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.867769e-01 | 0.006 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.878745e-01 | 0.005 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.878745e-01 | 0.005 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.878745e-01 | 0.005 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.878745e-01 | 0.005 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.884645e-01 | 0.005 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.887553e-01 | 0.005 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.887802e-01 | 0.005 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.888810e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.888810e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.894633e-01 | 0.005 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.898041e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.909391e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.909391e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.915992e-01 | 0.004 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.915992e-01 | 0.004 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.916659e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.921386e-01 | 0.003 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.922122e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.923312e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.931356e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.933900e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.937993e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.939389e-01 | 0.003 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.939389e-01 | 0.003 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.950696e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.950696e-01 | 0.002 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.953271e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.954331e-01 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.956961e-01 | 0.002 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.957153e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.959289e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.960712e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.963976e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.966849e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.969007e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.970696e-01 | 0.001 | 1 | 1 |
| Collagen degradation | R-HSA-1442490 | 9.974537e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.978062e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.980673e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.981541e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.982702e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.984871e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.984871e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.985027e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.985705e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.986129e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.986770e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.988150e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.988339e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.989309e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.989309e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.990328e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.991013e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.991760e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.994178e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.994425e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994613e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.995938e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996216e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.996543e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997434e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997595e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997595e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998118e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.998307e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998427e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.998481e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998557e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998671e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.998762e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999061e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999210e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999211e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999260e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999627e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999722e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999748e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999767e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999850e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999862e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999908e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999931e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999939e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999942e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999944e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999959e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999962e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999962e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999979e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999984e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999993e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999994e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999999e-01 | 0.000 | 1 | 1 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 1 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |